Home  Turmeric.com References  Turmeric References - Section vii

Turmeric References - Section vii

  1. Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals. Aggarwal, Bharat B. [ed.] Robert J. Cousins. Gainesville: Annual Reviews, August 2010, Annual Review of Nutrition, Vol. 30, pp. 173-199. DOI: 10.1146/annurev.nutr.012809.104755; http://www.annualreviews.org/doi/abs/10.1146/annurev.nutr.012809.104755. ISSN: 0199-9885.
  2. Obesity, Inflammation, and the Potential Application of Pharmaconutrition. Cave, Matt C., et al., et al. [ed.] Jeanette Hasse. 1, Dallas: SAGE Publications: American Society for Parenteral and Enteral Nutrition, February 2008, Nutrition in Clinical Practice, Vol. 23, pp. 16-34. DOI: 10.1177/011542650802300116; http://ncp.sagepub.com/content/23/1/16. ISSN: 0884-5336.
  3. Super Religare Laboratories Limited. Metabolic Syndrome: A Reversible Life-Threatening Condition. SRL Global Knowledge Forum. [Online] January 15, 2012. [Cited: April 16, 2013.] http://www.srlworld.com/innersense/Voice-127-Metabolic-Syndrome-Jan-2012-IS.pdf.
  4. The Relationship between Nonalcoholic Fatty Liver Disease and Colorectal Cancer: The Future Challenges and Outcomes of the Metabolic Syndrome. Muhidin, Said O., et al., et al. [ed.] Ahmed Almobarak. Article ID 637538, Baghdad: Hindawi Publishing Corporation, December 10, 2012, Journal of Obesity, Vol. 2012, pp. 1-8. DOI: 10.1155/2012/637538; http://www.hindawi.com/journals/jobe/2012/637538/. ISSN: 2090-0716.
  5. Validation of anti-aging drugs by treating age-related diseases. Blagosklonny, Mikhail V. [ed.] Mikhail V. Blagosklonny, Judith Campisi and David A. Sinclair. 3, Albany: Impact Journals LLC, March 2009, Aging, Vol. 1, pp. 281-288. eISSN: 1945-4589.
  6. Iqbal, Muzamal, et al., et al. Phytochemicals as a potential source for TNF-α inhibitors. [book auth.] Muzamal Iqbal. NMR-based metabolomics to identify bioactive compounds in herbs and fruits. Leiden: Natural Products Laboratory (NPL), Institute of Biology (IBL), Faculty of Science, Leiden University, 2013, 2, pp. 9-64. ISBN: 978-94-6203-348-1.
  7. Strayer, David S. and Rubin, Emanuel.  Cell Adaptation, Cell Injury and Cell Death. [ed.] Raphael Rubin, David S. Strayer and Emanuel Rubin. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 6. Philadelphia: Wolters Kluwer: Lippincott Williams & Wilkins, 2012, 1, pp. 1-46. ISBN: 978-1-60547-968-2.
  8. Preventive Effects of Curcumin on the Development of Azoxymethane-Induced Colonic Preneoplastic Lesions in Male C57BL/KsJ-db/db Obese Mice. Kubota, Masaya, et al., et al. [ed.] Leonard A. Cohen. 1, Valhalla: Taylor and Francis, 2012, Nutrition and Cancer, Vol. 64, pp. 72-79. DOI: 10.1080/01635581.2012.630554; http://www.tandfonline.com/doi/abs/10.1080/01635581.2012.630554#.VDq8izZOVD8. ISSN: 0163-5581.
  9. Molecular mechanisms of hypolipidemic effects of curcumin. Zingg, Jean-Marc, Hasan, Syeda T. and Meydani, Mohsen. [ed.] Angelo Azzi. 1, Boston: John Wiley & Sons, Inc.: International Union of Biochemistry and Molecular Biology, Inc., January/February 2013, Biofactors, Vol. 39, pp. 101-121. DOI: 10.1002/biof.1072; http://onlinelibrary.wiley.com/doi/10.1002/biof.1072/abstract. ISSN: 1872-8081.
  10. Curcumin Inhibits Adipogenesis in 3T3-L1 Adipocytes and Angiogenesis and Obesity in C57/BL Mice. Ejaz, Asma, et al., et al. [ed.] A. Catharine Ross. 5, University Park: American Society for Nutrition, May 2009, The Journal of Nutrition, Vol. 139, pp. 919-925. DOI: 10.3945/jn.108.100966; http://jn.nutrition.org/content/139/5/919. ISSN: 0022-3166.
  11. The study of insulin resistance and leptin resistance on the model of simplicity obesity rats by curcumin. Yu, Y., Hu, S.K. and Yan, H. [ed.] Junshi Chen. 11, Beijing: Chinese Medical Association, November 2008, Chinese Journal of Preventive Medicine, Vol. 42, pp. 818-822. ISSN: 0253-9624.
  12. Recent advances in the investigation of curcuminoids. Itokawa, Hideji, et al., et al. [ed.] Siu-wai Leung. 11, Macao: BioMed Central Ltd.: International Society for Chinese Medicine, September 17, 2008, Chinese Medicine, Vol. 3. DOI: 10.1186/1749-8546-3-11; http://www.cmjournal.org/content/3/1/11. ISSN: 1749-8546.
  13. Targeting collagen expression in alcoholic liver disease. Thompson, Kyle J., McKillop, Iain H. and Schrum, Laura W. [ed.] Lian-Sheng Ma. 20, Beijing: Baishideng Publishing Group Co., Limited, May 28, 2011, World Journal of Gastroenterology, Vol. 17, pp. 2473-2481. DOI: 10.3748/wjg.v17.i20.2473; http://www.wjgnet.com/1007-9327/full/v17/i20/2473.htm. ISSN: 1007-9327.
  14. Impaired Preadipocyte Differentiation in Human Abdominal Obesity - Role of Wnt, Tumor Necrosis Factor-α, and Inflammation Isakson, Petter, et al., et al. [ed.] Peter C. Butler. 7, Los Angeles: American Diabetes Association, July 2009, Diabetes, Vol. 58, pp. 1550-1557. DOI: 10.2337/db08-1770; http://diabetes.diabetesjournals.org/content/58/7/1550. ISSN: 1939-327X.
  15. Lydon, Chris. Deflating Your Spare Tire For a Longer, Leaner Life; Turn Off Your Fat Switch; Understanding the Risks of Leptin Resistance. Life Extension Magazine. [Online] February 2009. [Cited: March 18, 2015.] http://www.lef.org/magazine/mag2009/feb2009_Irvingia-Understanding-the-Risks-of-Leptin-Resistance_01.htm.
  16. Attenuation of fatty liver and prevention of hypercholesterolemia by extract of Curcuma longa through regulating the expression of CYP7A1, LDL-receptor, HO-1, and HMG-CoA reductase. Yiu, Wing-Fat, et al., et al. [ed.] Daryl B. Lund. 3, Madison: John Wiley & Sons, Inc.: Institute of Food Technologists®, April 2011, Journal of Food Science, Vol. 76, pp. H80-H89. DOI: 10.1111/j.1750-3841.2011.02042.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1750-3841.2011.02042.x/abstract. ISSN: 0022-1147.
  17. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Cao, Yihai. [ed.] Peter Kirkpatrick. 2, Cambridge: Macmillan Publishers Limited: Nature Publishing Group, February 2010, Nature Reviews: Drug Discovery, Vol. 9, pp. 107-115. DOI: 10.1038/nrd3055; http://www.nature.com/nrd/journal/v9/n2/full/nrd3055.html. ISSN: 1474-1776.
  18. Prasad, Sahdeo and Aggarwal, Bharat B. Turmeric, the Golden Spice: From Traditional Medicine to Modern Medicine. [ed.] Iris F.F. Benzie and Sissi Wachtel-Galor. Herbal Medicine: Biomolecular and Clinical Aspects. 2. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2011, 13, pp. 263-288. ISBN: 978-1-4398-0713-2.
  19. Frankenfield, David and Smith, J. Stanley. Nutritional Management of Cachexia of Chronic Illness. [ed.] Felix Bronner. Nutritional and Clinical Management of Chronic Conditions and Diseases. Boca Raton: CRC Press: Taylor & Francis Group, 2006, 13, pp. 265-276. ISBN-13: 978-0-8493-2765-0.
  20. Nahar, Lutfun and Sarker, Satyajit D. Phytochemistry of the Genus Curcuma. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 3, pp. 71-106. ISBN-13: 978-0-8493-7034-2.
  21. Molecular Targets of Nutraceuticals Derived from Dietary Spices: Potential Role in Suppression of Inflammation and Tumorigenesis. Aggarwal, Bharat B., et al., et al. [ed.] Steven R. Goodman. 8, Syracuse: SAGE: The Society for Experimental Biology and Medicine, August 2009, Experimental Biology and Medicine, Vol. 234, pp. 825-849. DOI: 10.3181/0902-MR-78; http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141288/. ISSN: 1535-3699.
  22. Nutraceuticals in dyslipidemia management. Kota, Sunil K., et al., et al. [ed.] Manash P. Baruah. 1, Mumbai: Medknow: ALLIANCE, January 1, 2013, Journal of Medical Nutrition and Nutraceuticals, Vol. 2, pp. 26-40. DOI: 10.4103/2278-019X.105328; http://www.jmnn.org/article.asp?issn=2278-019X;year=2013;volume=2;issue=1;spage=26;epage=40;aulast=Kota. ISSN: 2278-1870.
  23. Nutraceutical use in late-stage cancer. Wargovich, Michael J., et al., et al. [ed.] Avraham Raz and Kenneth V. Honn. 3, Detroit: Springer Science+Business Media, LLC, September 2010, Cancer and Metastasis Reviews, Vol. 29, pp. 503-510. DOI: 10.1007/s10555-010-9240-5; http://link.springer.com/article/10.1007%2Fs10555-010-9240-5. eISSN: 1573-7233.
  24. Chemopreventive effects of natural dietary compounds on cancer development. Pan, Min-Hsiung and Ho, Chi-Tang. [ed.] Robert D. Eagling. 11, Cambridge: The Royal Society of Chemistry, November 1, 2008, Chemical Society Reviews, Vol. 37, pp. 2558-2574. DOI: 10.1039/b801558a; http://pubs.rsc.org/en/content/articlepdf/2008/cs/b801558a. ISSN: 0306-0012.
  25. Phytochemical flavonols, carotenoids and the antioxidant properties of a wide selection of Fijian fruit, vegetables and other readily available foods. Lako, Jimaima, et al., et al. [ed.] G.G. Birch. 4, Reading: Elsevier Ltd., 2007, Food Chemistry, Vol. 101, pp. 1727-1741. DOI: 10.1016/j.foodchem.2006.01.031; http://www.sciencedirect.com/science/article/pii/S0308814606000872. ISSN: 0308-8146.
  26. Prasad, Sahdeo, Gupta, Subash C. and Aggarwal, Bharat B. Micronutrients and Cancer: Add Spice to Your Life. [ed.] Sharmila Shankar and Rakesh K. Srivastava. Nutrition, Diet and Cancer. New York: Springer Science+Business Media B.V., 2012, 2, pp. 23-48. ISBN: 978-94-007-2922-3.
  27. Khan, Nasiruddin, et al., et al. Resveratrol and Bioactive Flavonoids in Immune Function. [ed.] Ronald Ross Watson, Sherma Zibadi and Victor R. Preedy. Dietary Components and Immune Function. New York: Springer Science+Business Media, LLC, 2010, 23, pp. 397-420. ISBN: 978-1-60761-061-1; DOI: 10.1007/978-1-60761-061-8.
  28. Das, Samarjit, Vasanthi, Hannah R. and Das, Dipak K. Resveratrol: Biochemistry and Functions. [ed.] Cesar G. Fraga. Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology. Hoboken: John Wiley & Sons, Inc., 2010, 14, pp. 299-330. ISBN: 978-0-470-28721-7.
  29. Balakrishnan, K.V. Postharvest Technology and Processing of Turmeric. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 8, pp. 193-256. ISBN-13: 978-0-8493-7034-2.
  30. Prasad, Kedar N. Micronutrients for Improvement of the Standard Therapy in Cancer. Micronutrients in Health and Disease. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2011, 8, pp. 133-166. ISBN: 978-1-4398-2106-0.
  31. Codario, Ronald A. Pathophysiology of Type-2 Diabetes. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome. [ed.] Neil S. Skolnik. 2. New York: Humana Press: Springer Science+Business Media, LLC, 2011, 1, pp. 1-14. ISBN: 978-1-60327-440-1; DOI: 10.1007/978-1-60327-441-8.
  32. Tumor Angiogenesis as a Target for Dietary Cancer Prevention. Li, William W., et al., et al. [ed.] Kalpna Gupta. Article ID 879623, Minneapolis: Hindawi Publishing Corporation, September 29, 2011, Journal of Oncology, Vol. 2012, pp. 1-23. DOI: 10.1155/2012/879623; http://www.hindawi.com/journals/jo/2012/879623/. ISSN: 1687-8469.
  33. Quercetin Preserves 𝛽-Cell Mass and Function in Fructose-Induced Hyperinsulinemia through Modulating Pancreatic Akt/FoxO1 Activation. Li, Jian-Mei, et al., et al. [ed.] Ravirajsinh N. Jadeja. Article ID 303902, New York; Cairo: Hindawi Publishing Corporation, January 26, 2013, Evidence-Based Complementary and Alternative Medicine, Vol. 2013, pp. 1-12. DOI: 10.1155/2013/303902; http://www.hindawi.com/journals/ecam/2013/303902/. eISSN: 1741-4288.
  34. Phytochemicals with potential effects in metabolic syndrome prevention and therapy. Holubková, Andrea, et al., et al. [ed.] Aleksander Pavko. 2, Slovenija: Slovenian Chemical Society, 2012, Acta Chimica Slovaca, Vol. 5, pp. 186-199. ISSN: 1318-0207.
  35. Aggarwal, Bharat B., et al., et al. Curcumin — Biological and Medicinal Properties. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, 2007, 10, pp. 298-348. ISBN-13: 978-0-8493-7034-2.
  36. Foods for the prevention of diabetes: how do they work? Thomas, Theodoros and Pfeiffer, Andreas F.H. [ed.] Jesse Roth. 1, Manhasset: John Wiley & Sons, Ltd., January 3, 2012, Diabetes Metabolism Research and Reviews, Vol. 28, pp. 25-49. DOI: 10.1002/dmrr.1229; http://onlinelibrary.wiley.com/doi/10.1002/dmrr.1229/abstract. ISSN: 1520-7552.
  37. Hypoglycemic Effects of Turmeric (Curcuma longa L. Rhizomes) on Genetically Diabetic KK-Ay Mice. Kuroda, Minpei, et al., et al. 5, Tokyo: International Academic Printing Co., Ltd.: The Pharmaceutical Society of Japan, May 2005, Biological and Pharmaceutical Bulletin, Vol. 28, pp. 937-939. DOI: 10.1248/bpb.28.937; https://www.jstage.jst.go.jp/article/bpb/28/5/28_5_937/_article. ISSN: 0918-6158.
  38. Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases. Sahagún, D. Ortuño, et al., et al. [ed.] Bruce Blumberg. Article ID 318613, Guadalajara: Hindawi Publishing Corporation, October 23, 2012, PPAR Research, Vol. 2012, pp. 1-17. DOI: 10.1155/2012/318613; http://www.hindawi.com/journals/ppar/2012/318613/. ISSN: 1687-4757.
  39. Chemical Composition and Product Quality Control of Turmeric (Curcuma longa L.). Li, Shiyou, et al., et al. [ed.] Shiyou Li and Shilin Chen. Nacogdoches; Beijing: Bentham Open, 2011, Pharmaceutical Crops, Vol. 2, pp. 28-54. DOI: 10.2174/2210290601102010028; http://benthamopen.com/ABSTRACT/TOPHARMCJ-2-28. ISSN: 2210-2906.
  40. Adiponectin in Cardiovascular Inflammation and Obesity. Aprahamian, Tamar R. and Sam, Flora. [ed.] Elena Aikawa. Article ID 376909, Boston: Hindawi Publishing Corporation, June 10, 2011, International Journal of Inflammation, Vol. 2011, pp. 1-8. DOI: 10.4061/2011/376909; http://www.hindawi.com/journals/iji/2011/376909/. eISSN: 2042-0099.
  41. AMP-activated Protein Kinase: An Emerging Drug Target to Regulate Imbalances in Lipid and Carbohydrate Metabolism to Treat Cardio-Metabolic Diseases. Srivastava, Rai Ajit K., et al., et al. [ed.] Edward A. Dennis and Joseph L. Witztum. 12, San Diego: American Society for Biochemistry and Molecular Biology, July 13, 2012, The Journal of Lipid Research, Vol. 53, pp. 2490-2514. DOI: 10.1194/jlr.R025882; http://www.jlr.org/content/53/12/2490. ISSN: 0022-2275.
  42. Phytochemicals as Potential Agents for Prevention and Treatment of Obesity and Metabolic Diseases. Park, Taesun and Kim, Yunjung. [ed.] Atta-ur-Rahman and M. Iqbal Choudhary. 36, Karachi: Bentham Science Publishers, 2011, Anti-Obesity Drug Discovery and Development, Vol. 1, pp. 150-185. eISBN: 978-1-60805-163-2.
  43. Screening of selected Asian spices for anti obesity-related bioactivities. Yuliana, Nancy Dewi, et al., et al. [ed.] G.G. Birch. 4, Reading: Elsevier Ltd., June 15, 2011, Food Chemistry, Vol. 126, pp. 1724-1729. DOI: 10.1016/j.foodchem.2010.12.066; http://www.sciencedirect.com/science/article/pii/S0308814610016870. ISSN: 0308-8146.
  44. Teitel, Ariel D. C-reactive protein. MedlinePlus. [Online] February 11, 2013. [Cited: March 18, 2015.] http://www.nlm.nih.gov/medlineplus/ency/article/003356.htm.
  45. A Review on Anti-Inflammatory Activity of Monoterpenes. Sá, Rita de Cássia da Silveira e, Andrade, Luciana Nalone and Sousa, Damião Pergentino de. [ed.] Derek J. McPhee. 18, Emeryville: MDPI AG, January 18, 2013, Molecules, Vol. 2013, pp. 1227-1254. DOI: 10.3390/molecules18011227; http://www.mdpi.com/1420-3049/18/1/1227. ISSN: 1420-3049.
  46. Systemic Inflammation in Morbidly Obese Subjects: Response to Oral Supplementation with Alpha-Linolenic Acid. Faintuch, Joel, et al., et al. [ed.] Mervyn Deitel. 3, Toronto: Springer-Verlag, March 1, 2007, Obesity Surgery, Vol. 17, pp. 341-347. DOI: 10.1007/s11695-007-9062-x; http://link.springer.com/article/10.1007%2Fs11695-007-9062-x. ISSN: 0960-8923.
  47. Studies on Chemistry and Biological Activities of Curcuma Longa Linn - A Review. Reddy, Y. Surendra, et al., et al. [ed.] M. William Carey. 1, Andhra Pradesh: KMR Pharma Welfare Association, January 24, 2011, International Journal of Advances in Pharmaceutical Research, Vol. 2, pp. 26-36. eISSN: 2230-7583.
  48. Duke, James A., Bogenschutz-Godwin, Mary Jo and duCellier, Judi. CRC Handbook of Medicinal Spices. Boca Raton: CRC Press LLC, 2003. ISBN: 0-8493-1279-5.
  49. Dietary Polyphenols and Their Biological Significance. Han, Xiuzhen, Shen, Tao and Lou, Hongxiang. [ed.] Michael N. Hall. 9, Basel: MDPI - Open Access Publishing, September 12, 2007, International Journal of Molecular Sciences, Vol. 8, pp. 950-988. DOI: 10.3390/i8090950; http://www.mdpi.com/1422-0067/8/9/950. ISSN: 1422-0067.
  50. Boik, John. Natural Compounds in Cancer Therapy: Promising Nontoxic Antitumor Agents from Plants & Other Natural Sources. [ed.] Silvine Farnell. s.l.: Oregon Medical Press, LLC, 2001. ISBN: 0-9648280-1-4.
  51. Sarker, Satyajit D. and Nahar, Lutfun. Bioactivity of Turmeric. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 9, pp. 258-285. ISBN-13: 978-0-8493-7034-2.
  52. Effect of NCB-02, Atorvastatin and Placebo on Endothelial Function, Oxidative Stress and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus. Usharani, P., et al., et al. [ed.] Anton van Rensburg. 4, Auckland: Springer International Publishing, July 1, 2008, Drugs in R & D, Vol. 9, pp. 243-250. DOI: 10.2165/00126839-200809040-00004; http://link.springer.com/article/10.2165%2F00126839-200809040-00004. ISSN: 1174-5886.
  53. Effect of curcumin on high-sensitivity C-reactive protein and blood-lipids in patients with coronary heart disease. Zhang, Qing-bin and Liu, Fu-yuan.  2, s.l.: CNKI, February 2007, Chinese Traditional Patent Medicine, Vol. 2007, pp. 164-167. ISSN: 1001-1528.
  54. Ferulic Acid - A Comprehensive Pharmacology of an Important Bioflavonoid. Gohil, Kashmira J., Kshirsagar, Shashank B. and Sahane, Rajkumari S. [ed.] Shashi Alok. 1, Jhansi: Society of Pharmaceutical Sciences & Research, March 2012, International Journal of Pharmaceutical Sciences and Research, Vol. 3, pp. 700-710. ISSN: 0975-8232.
  55. Fisetin Inhibits Hyperglycemia-Induced Proinflammatory Cytokine Production by Epigenetic Mechanisms. Kim, Hye Joo, Kim, Seong Hwan and Yun, Jung-Mi. [ed.] Menaka C. Thounaojam. Article ID 639469, Nashville: Hindawi Publishing Corporation, December 3, 2012, Evidence-Based Complementary and Alternative Medicine, Vol. 2012, pp. 1-10. DOI: 10.1155/2012/639469; http://www.hindawi.com/journals/ecam/2012/639469/. ISSN: 1741-427X.
  56. Attokaran, Mathew. Turmeric: Curcuma longa L (Zingiberaceae). Natural Food Flavors and Colorants. Ames: Blackwell Publishing Ltd. and Institute of Food Technologists, 2011, 98, pp. 391-398. ISBN: 978-0-8138-2110-8.
  57. The Biochemical and Cellular Basis for Nutraceutical Strategies to Attenuate Neurodegeneration in Parkinson's Disease. Mazzio, Elizabeth A., Close, Fran and Soliman, Karam F.A. [ed.] Andrei Alexandrescu. 1, Storrs: MDPI AG, January 17, 2011, International Journal of Molecular Sciences, Vol. 12, pp. 506-569. DOI: 10.3390/ijms12010506; http://www.mdpi.com/1422-0067/12/1/506. ISSN: 1422-0067.
  58. Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells. Ganji, Shobha H., et al., et al. [ed.] Steve E. Humphries. 1, London: Elsevier Inc., January 2009, Atherosclerosis, Vol. 201, pp. 68-75. DOI: 10.1016/j.atherosclerosis.2008.04.044; http://www.atherosclerosis-journal.com/article/S0021-9150(08)00276-1/abstract. ISSN: 0021-9150.
  59. The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome. Thoenes, M., et al., et al. [ed.] Graham Jackson. 11, London: John Wiley & Sons, Inc., November 2007, International Journal of Clinical Practice, Vol. 61, pp. 1942-1948. DOI: 10.1111/j.1742-1241.2007.01597.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1742-1241.2007.01597.x/abstract. ISSN: 1368-5031.
  60. Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system. Blaylock, Russell L. and Maroon, Joseph. [ed.] James I. Ausman. 19, Los Angeles: Medknow, February 15, 2012, Surgical Neurology International®, Vol. 3. DOI: 10.4103/2152-7806.92935; http://www.surgicalneurologyint.com/article.asp?issn=2152-7806;year=2012;volume=3;issue=1;spage=19;epage=19;aulast=Blaylock. ISSN: 2152-7806.
  61. Molecular Pathways of Endothelial Cell Activation for (Targeted) Pharmacological Intervention of Chronic Inflammatory Diseases. Kuldo, Joanna M., et al., et al. [ed.] Dimitri P. Mikhailidis. 1, London: Bentham Science Publishers, January 2005, Current Vascular Pharmacology, Vol. 3, pp. 11-39. DOI: 10.2174/1570161052773898; http://www.eurekaselect.com/80027/article. 1570-1611.
  62. Nrf2, a Guardian of Healthspan and Gatekeeper of Species Longevity. Lewis, Kaitlyn N., et al., et al. [ed.] Harold Heatwole. 5, Raleigh: Oxford University Press: The Society for Integrative and Comparative Biology, November 2010, Integrative and Comparative Biology, Vol. 50, pp. 829-843. DOI: 10.1093/icb/icq034; http://icb.oxfordjournals.org/content/50/5/829. 1540-7063.
  63. Dietary phenolics: chemistry, bioavailability and effects on health. Crozier, Alan, Jaganath, Indu B. and Clifford, Michael N. 8, s.l.: The Royal Society of Chemistry, August 2009, Natural Product Reports, Vol. 26, pp. 1001-1043. DOI: 10.1039/b802662a; http://pubs.rsc.org/en/Content/ArticleLanding/2009/NP/b802662a#!divAbstract. ISSN: 0265-0568.
  64. Chemopreventive potential of geraniol in 7,12-dimethylbenz(a) anthracene (DMBA) induced skin carcinogenesis in Swiss albino mice. Manoharan, S. and Selvan, M. Vasantha. [ed.] R.C. Dalela. 2, Lucknow: Triveni Enterprises, March 2012, Journal of Environmental Biology, Vol. 33, pp. 255-260. ISSN: 0254-8704.
  65. Chempakam, B. and Parthasarathy, V.A. Turmeric. [ed.] V.A. Parthasarathy, B. Chempakam and T. John Zachariah. Chemistry of Spices. Oxfordshire: CAB International, 2008, 6, pp. 97-123. ISBN: 978-1-84593-405-7.
  66. The Role of Nutraceutical Supplements in the Treatment of Dyslipidemia. Houston, Mark. [ed.] Michael A. Weber. 2, Greenwich: John Wiley & Sons, Inc., February 2012, The Journal of Clinical Hypertension, Vol. 14, pp. 121-132. DOI: 10.1111/j.1751-7176.2011.00576.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7176.2011.00576.x/abstract. eISSN: 1751-7176.
  67. The Role of Chronic Inflammation in Cardiovascular Disease and its Regulation by Nutrients. Osiecki, Henry. [ed.] Kathleen A. Head. 1, Napa: Thorne Research, Inc., March 2004, Alternative Medicine Review, Vol. 9, pp. 32-53. ISSN: 1089-5159.
  68. An hydroalcoholic extract of Curcuma longa lowers the apo B:apo A ratio Implications for atherogenesis prevention. Ramírez-Boscá, Ana, et al., et al. [ed.] Bernard L. Strehler. 1-2, Los Angeles: Elsevier Science Ireland Ltd., October 20, 2000, Mechanisms of Ageing and Development, Vol. 119, pp. 41-47. DOI: 10.1016/S0047-6374(00)00169-X; http://www.sciencedirect.com/science/article/pii/S004763740000169X. ISSN: 0047-6374.
  69. Blaylock, Russell L. What Drug Companies Don’t Want You to Know about Heart Disease, Cholesterol, and Obesity. The Blaylock Wellness Report. February 2008, Vol. 5, 2.
  70. Molecular mechanisms for anti-aging by natural dietary compounds. Pan, Min-Hsiung, et al., et al. [ed.] Hans-Ulrich Humpf. 1, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, January 2012, Molecular Nutrition & Food Research, Vol. 56, pp. 88-115. DOI: 10.1002/mnfr.201100509; http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201100509/abstract. ISSN: 1613-4133.
  71. Druggability of lead compounds from turmeric (Curcuma longa). Wilson, M., Balaji, S. and Eapen, S.J. 2006, Journal of Medicinal and Aromatic Plant Sciences, Vol. 28, pp. 384-390. ISSN: 0253-7125.
  72. Composition and Antioxidant Properties of Essential Oils from Curcuma rhizome. Tsai, Snu-Yao, et al., et al. [ed.] Shian-Shyong Tseng. 1, Taichung City: Asia University, June 2011, Asian Journal of Arts and Sciences, Vol. 2, pp. 57-66. ISSN: 2221-4224.
  73. Prevention and Therapy of Cancer by Dietary Monoterpenes. Crowell, Pamela L.  [ed.] John W. Suttie. 3, Bethesda: American Society for Nutrition, March 1, 1999, The Journal of Nutrition, Vol. 129, pp. 775S-778S. ISSN: 0022-3166.
  74. Phytochemistry and mode of action of some tropical spices in the management of type-2 diabetes and hypertension. Adefegha, Stephen Adeniyi and Oboh, Ganiyu. [ed.] Himanshu Gupta, et al., et al. 7, s.l.: Academic Journals, February 22, 2013, African Journal of Pharmacy and Pharmacology, Vol. 7, pp. 332-346. ISSN: 1996-0816.
  75. Amelioration of Obesity, Glucose Intolerance, and Oxidative Stress in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats by Combination Consisting of "Curcumin with Piperine and Quercetin". Kaur, Ginpreet and Chintamaneni, Meena. [ed.] T. Kumai and M.A. Prendergast. Article ID 957283, Mumbai: Hindawi Publishing Corporation, March 8, 2012, ISRN Pharmacology, Vol. 2012, pp. 1-7. DOI: 10.5402/2012/957283; http://www.hindawi.com/journals/isrn/2012/957283/. ISSN: 2090-5165.
  76. Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats. Li, Jian-Mei, et al., et al. [ed.] Michael H. Nathanson. 5, New Haven: John Wiley & Sons, Inc.: American Association for the Study of Liver Diseases, May 2010, Hepatology, Vol. 51, pp. 1555-1566. DOI: 10.1002/hep.23524; http://onlinelibrary.wiley.com/doi/10.1002/hep.23524/abstract. eISSN: 1527-3350.
  77. Impact of Dietary Polyphenols on Carbohydrate Metabolism. Hanhineva, Kati, et al., et al. [ed.] Andrei Alexandrescu. 4, Basel: MDPI AG, March 31, 2010, International Journal of Molecular Sciences, Vol. 11, pp. 1365-1402. DOI: 10.3390/ijms11041365; http://www.mdpi.com/1422-0067/11/4/1365. ISSN: 1422-0067.
  78. Dietary Polyphenols and Obesity. Meydani, Mohsen and Hasan, Syeda T. [ed.] Peter Howe and Jonathan Buckley. 7, Callaghan; Adelaide: MDPI - Open Access Publishing, July 8, 2010, Nutrients, Vol. 2, pp. 737-751. DOI: 10.3390/nu2070737; http://www.mdpi.com/2072-6643/2/7/737. ISSN: 2072-6643.
  79. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: A roadmap from energy metabolism to stem cell renewal and aging. Menendez, Javier A., et al., et al. [ed.] M.V. Blagosklonny. 21, Buffalo: Landes Bioscience, November 1, 2011, Cell Cycle, Vol. 10, pp. 3658-3677. DOI: 10.4161/cc.10.21.18128; http://www.tandfonline.com/doi/abs/10.4161/cc.10.21.18128#.VPTMJjZOWpo. ISSN: 1538-4101.
  80. Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion. Kim, Su-Ryun, et al., et al. [ed.] Jeffrey D. Blaustein. 2, Boston: The Endocrine Society, December 20, 2011, Endocrinology, Vol. 153, pp. 554-563. DOI: 10.1210/en.2011-1413; http://press.endocrine.org/doi/abs/10.1210/en.2011-1413. ISSN: 0013-7227.
  81. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). Ulmer, Hanno, et al., et al. [ed.] Beth Y. Karlan. 2, West Hollywood: Elsevier B.V., May 2012, Gynecologic Oncology, Vol. 125, pp. 330-335. DOI: 10.1016/j.ygyno.2012.01.052; http://www.gynecologiconcology-online.net/article/S0090-8258(12)00085-6/abstract. ISSN: 0090-8258.
  82. Serum Adiponectin Level and Different Kinds of Cancer: A Review of Recent Evidence. Izadi, Vajihe, Farabad, Elaheh and Azadbakht, Leila. [ed.] N. Fujimoto, et al., et al. Article ID 982769, s.l.: Hindawi Publishing Corporation, November 18, 2012, ISRN Oncology, Vol. 2012. DOI: 10.5402/2012/982769; http://www.hindawi.com/journals/isrn/2012/982769/. eISSN: 2090-567X.
  83. Garcia, F. and Chambers, S.K. Endometrial Cancer Prevention. [ed.] David S. Alberts and Lisa M. Hess. Fundamentals of Cancer Prevention. 2. s.l.: Springer-Verlag Berlin Heidelberg, 2008, pp. 475-494. ISBN: 978-3-540-68985-0; DOI: 10.1007/978-3-540-68986-7.
  84. Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS Adipocytes. Derdemezis, Christos S., et al., et al.  [ed.] Tzi-Bunb Ng. Article ID 285618, Hong Kong: Hindawi Publishing Corporation, July 23, 2011, Biochemistry Research International, Vol. 2011, pp. 1-5. DOI: 10.1155/2011/285618; http://www.hindawi.com/journals/bri/2011/285618/. eISSN: 2090-2247.
  85. Codario, Ronald A. Preface. [ed.] Neil S. Skolnik. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome. 2. New York: Humana Press: Springer Science+Business Media, LLC, 2011. ISBN: 978-1-60327-440-1; DOI: 10.1007/978-1-60327-441-8.
  86. Marcovitch, Harvey. Black's Medical Dictionary. 41. London: A & C Black Publishers Limited, 2005. ISBN: 0-7136-6146-1.
  87. Curcumin Extract for Prevention of Type 2 Diabetes. Chuengsamarn, Somlak, et al., et al. [ed.] William T. Cefalu. 11, Alexandria: American Diabetes Association, November 2012, Diabetes Care, Vol. 35, pp. 2111-2112. DOI: 10.2337/dc12-0116; http://care.diabetesjournals.org/content/35/11/2121. ISSN: 1935-5548.
  88. Committee on Herbal Medicinal Products. Assessment Report on Curcuma Longa L. Rhizoma. London: European Medicines Agency, 2009. EMEA/HMPC/456848/2008.
  89. Diabetes Epidemic in India: Risk Factors, Symptoms and Treatment. Abhinov, T., et al., et al. [ed.] B. Pragati Kumar. 2, Vijayawada: Pragati Publication PVT Ltd., March-April 2013, Indian Journal of Research in Pharmacy and Biotechnology , Vol. 1, pp. 234-243. eISSN: 2320-3471.
  90. Adiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis. Li, Shanshan, et al., et al. [ed.] Catherine D. DeAngelis. 2, Baltimore: American Medical Association, July 8, 2009, JAMA, Vol. 302, pp. 179-188. DOI: 10.1001/jama.2009.976; http://jama.jamanetwork.com/article.aspx?articleid=184206. ISSN: 0098-7484.
  91. Codario, Ronald A. Guidelines and Classifications. [ed.] Neil S. Skolnik. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome. 2. New York: Humana Press: Springer Science+Business Media, LLC, 2011, 2, pp. 15-32. ISBN: 978-1-60327-440-1; DOI: 10.1007/978-1-60327-441-8.
  92. Bjelakovic, G., et al., et al. Hypoglycemia as a Pathological Result in Medical Praxis. [ed.] David Wagner. Type 1 Diabetes Complications. Rijeka: InTech, 2011, 5, pp. 109-142. ISBN: 978-953-307-788-8.
  93. Codario, Ronald A.  Nutrition. [ed.] Neil S. Skolnik. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome. 2. New York: Humana Press: Springer Science+Business Media, LLC, 2011, 4, pp. 47-66. ISBN: 978-1-60327-440-1; DOI: 10.1007/978-1-60327-441-8.
  94. Curcumin Improves Insulin Sensitivity and Ameliorates Serum Pro-inflammatory Cytokines Levels in Diabetes Rat model Irrespective of type of Diabetes. Mahfouz, Mohamed Khaled Mohamed. [ed.] Hongbao Ma. 6, East Lansing: Marsland Press, June 25, 2011, Journal of American Science, Vol. 7, pp. 794-799. ISSN: 1545-1003.
  95. Retinal Redox Stress and Remodeling in Cardiometabolic Syndrome and Diabetes. Yang, Ying, et al., et al. [ed.] Kenneth Maiese. 6, New York; Cairo: Hindawi Publishing Corporation, Nov-Dec 2010, Oxidative Medicine and Cellular Longevity, Vol. 3, pp. 392-403. DOI: 10.4161/oxim.3.6.14786; http://www.hindawi.com/journals/omcl/2010/193157/abs/. ISSN: 1942-0900.
  96. Antidiabetic and antioxidant potentials of spent turmeric oleoresin, a by-product from curcumin production industry. Nampoothiri, Suresh V, et al., et al. [ed.] Jeffrey M. Bethony, et al., et al. Supplement 1, Washington, D.C.; Livorno; Leicester: Elsevier (Singapore) Pte Ltd., October 2012, Asian Pacific Journal of Tropical Disease, Vol. 2, pp. S169-S172. DOI: 10.1016/S2222-1808(12)60146-7; http://www.sciencedirect.com/science/article/pii/S2222180812601467. ISSN: 2222-1808.
  97. Turmeric (Curcuma longa L.) volatile oil inhibits key enzymes linked to type 2 diabetes. Lekshmi, P.C., et al., et al. [ed.] Furio Brighenti. 7, Parma: Informa Plc, November 2012, International Journal of Food Sciences and Nutrition, Vol. 63, pp. 832-834. DOI: 10.3109/09637486.2011.607156; http://informahealthcare.com/doi/abs/10.3109/09637486.2011.607156. ISSN: 0963-7486.
  98. Turmerin, the antioxidant protein from turmeric (Curcuma longa) exhibits antihyperglycaemic effects. Lekshmi, P.C., et al., et al. [ed.] Armandodoriano Bianco. 17, Roma: Taylor & Francis Group, 2012, Natural Product Research, Vol. 26, pp. 1654-1658. DOI: 10.1080/14786419.2011.589386; http://www.tandfonline.com/doi/abs/10.1080/14786419.2011.589386#.VPDcmTZOWpp. ISSN: 1478-6419.
  99. Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjects. Wickenberg, Jennie, Ingemansson, Sandra Lindstedt and Hlebowicz, Joanna. [ed.] Nehme Gabriel. 43, Leesburg: BioMed Central Ltd, October 12, 2010, Nutrition Journal, Vol. 9. DOI: 10.1186/1475-2891-9-43; http://www.nutritionj.com/content/9/1/43. ISSN: 1475-2891.
  100. Remadevi, R., Surendran, E. and Kimura, Takeatsu. Turmeric in Traditional Medicine. [ed.] P. N. Ravindran, K. Nirmal Babu and K. Sivaraman. Turmeric: The Genus Curcuma. Boca Raton: CRC Press: Taylor & Francis Group, 2007, 12, pp. 409-436. ISBN-13: 978-0-8493-7034-2.
  101. Clinical Study of Turmeric (Curcuma longa L.) and Garlic (Allium sativum L.) Extracts as Antihyperglycemic and Antihyperlipidemic Agent in Type-2 Diabetes-Dyslipidemia Patients. Sukandar, E.Y., et al., et al.[ed.] Majid Y. Moridani. 4, Denver: Asian Network for Scientific Information, 2010, International Journal of Pharmacology, Vol. 6, pp. 456-463. ISSN: 1811-7775.
  102. Evaluation of Traditional Indian Antidiabetic Medicinal Plants for Human Pancreatic Amylase Inhibitory Effect In Vitro. Ponnusamy, Sudha, et al., et al. Article ID 515647, New York; Cairo: Hindawi Publishing Corporation, 2011, Evidence-Based Complementary and Alternative Medicine, Vol. 2011, pp. 1-10. DOI: 10.1155/2011/515647; http://www.hindawi.com/journals/ecam/2011/515647/. eISSN: 1741-4288.
  103. Dietary Curcumin Significantly Improves Obesity-Associated Inflammation and Diabetes in Mouse Models of Diabesity. Weisberg, Stuart P., Leibel, Rudolph and Tortoriello, Drew V. [ed.] Jeffrey D. Blaustein. 7, Boston: The Endocrine Society, July 2008, Endocrinology, Vol. 149, pp. 3549-3558. DOI: 10.1210/en.2008-0262; http://press.endocrine.org/doi/abs/10.1210/en.2008-0262. ISSN: 0013-7227.
  104. Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2. Lin, Jianguo and Chen, Anping. [ed.] I.T. Huhtaniemi. 2, London: Elsevier Ireland Ltd., February 20, 2010, Molecular and Cellular Endocrinology, Vol. 333, pp. 160-171. DOI: 10.1016/j.mce.2010.12.028; http://www.sciencedirect.com/science/article/pii/S0303720710006210. ISSN: 0303-7207.
  105. USDA Database for Standard Reference. NutriBase 7 Clinical Edition. s.l.: CyperSoft, 2007.
  106. The Role of Magnesium in Hypertension and Cardiovascular Disease. Houston, Mark. [ed.] Michael A. Weber. 11, New York: Wiley Periodicals, Inc., November 2011, The Journal of Clinical Hypertension, Vol. 13, pp. 843-847. DOI: 10.1111/j.1751-7176.2011.00538.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7176.2011.00538.x/abstract. eISSN: 1751-7176.
  107. Effects of ingested turmeric oleoresin on glucose and lipid metabolisms in obese diabetic mice: a DNA microarray study. Honda, Shinichi, et al., et al. [ed.] James N. Seiber. 24, Davis: American Chemical Society, November 29, 2006, Journal of Agricultural and Food Chemistry, Vol. 54, pp. 9055-9062. DOI: 10.1021/jf061788t; http://pubs.acs.org/doi/abs/10.1021/jf061788t. ISSN: 0021-8561.
  108. High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy. Purwata, Thomas Eko. [ed.] Howard S. Smith. Albany: Dove Medical Press, June 29, 2011, Journal of Pain Research, Vol. 4, pp. 169-175. DOI: 10.2147/JPR.S21751; http://www.dovepress.com/high-tnf-alpha-plasma-levels-and-macrophages-inos-and-tnf-alpha-expres-peer-reviewed-article-JPR. ISSN: 1178-7090.
  109. Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats. Soetikno, Vivian, et al., et al. [ed.] Hans-Ulrich Humpf. 11, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, November 2011, Molecular Nutrition & Food Research, Vol. 55, pp. 1655-1665. DOI: 10.1002/mnfr.201100080; http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201100080/abstract. eISSN: 1613-4133.
  110. Curcumin and Turmeric Delay Streptozotocin-Induced Diabetic Cataract in Rats. Suryanarayana, Palla, et al., et al. [ed.] Robert N. Frank. 6, Detroit: Association for Research in Vision and Ophthalmology, June 2005, Investigative Ophthalmology & Visual Science, Vol. 46, pp. 2092-2099. DOI: 10.1167/iovs.04-1304; http://www.iovs.org/content/46/6/2092. eISSN: 1552-5783.
  111. Shankar, Sharmila, Singh, Brahma N. and Srivastava, Rakesh K. Plant Polyphenols and Their Role in Cancer Prevention and Chemotherapy. [ed.] Sharmila Shankar and Rakesh K. Srivastava. Nutrition, Diet and Cancer. New York: Springer Science+Business Media B.V., 2012, 10, pp. 209-234. ISBN: 978-94-007-2922-3.
  112. A pilot study on the effects of a polyherbal formulation cream on diabetic foot ulcers. Viswanathan, Vijay, et al., et al. [ed.] K. Satyanarayana. 2, New Delhi: Indian Council of Medical Research , August 2011, Indian Journal of Medical Research , Vol. 134, pp. 168-173. ISSN: 0971-5916.
  113. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Na, Li-Xin, et al., et al. [ed.] Hans-Ulrich Humpf. 9, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, September 2013, Molecular Nutrition & Food Research, Vol. 57, pp. 1569-1577. DOI: 10.1002/mnfr.201200131; http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201200131/abstract. ISSN: 1613-4133.
  114. Curcumin/Irbesartan Combination Improves Insulin Sensitivity and Ameliorates Serum Pro-inflammatory Cytokines levels in Diabetes Rat model. Mahfouz, Mohamed Khaled Mohamed. [ed.] Hongbao Ma. 11, East Lansing: Marsland Press, 2010, Journal of American Science, Vol. 6, pp. 1051-1059. ISSN: 1545-1003.
  115. Increased Germ Cell Apoptosis During Testicular Development And Maturation By Experimentally Induced Transient And Persistent Hypothyroidism. Sahoo, Dipak K. [ed.] Majid Y. Moridani. 12, s.l.: Webmed Limited, December 9, 2013, BIOCHEMISTRY, Vol. 4, pp. 456-463. DOI: 10.9754/journal.wplus.2013.00209; http://www.webmedcentralplus.com/article_view/209. ISSN: 2046-1690.
  116. Cracknell, Grant, Hassed, Craig, and Phelps, Kerryn. Endocrinology. [ed.] Kerryn Phelps and Craig Hassed. General Practice: The Integrative Approach. Chatswood: Elsevier Australia, 2010, 29, pp. 339-364. ISBN-13: 978-0-72-953804-6.
  117. Dharmananda, Subhuti. Treatments for Thyroid Diseases with Chinese Herbal Medicine. Institute for Traditional Medicine. [Online] [Cited: January 12, 2015.] http://www.itmonline.org/arts/thyroid.htm.
  118. Tirtha, Swami Sadashiva. The Ãyurveda Encyclopedia: Natural Secrets to Healing, Prevention & Longevity. Bayville: Ayurveda Holistic Center Press, 2005. ISBN: 0-9658042-2-4.
  119. Effect of Turmeric and its Active Principle Curcumin on T3-Induced Oxidative Stress and Hyperplasia in Rat Kidney: A Comparison. Samanta, Luna, et al., et al. [ed.] Praveen Sharma. 4, Jaipur: Springer-Verlag, October 1, 2010, Indian Journal of Clinical Biochemistry, Vol. 25, pp. 393-397. DOI: 10.1007/s12291-010-0046-6; http://link.springer.com/article/10.1007%2Fs12291-010-0046-6. ISSN: 0970-1915.
  120. Testicular Protection From Thyroid Hormone Mediated Oxidative Stress. Sahoo, Dipak K. 5, s.l.: Webmed Limited, May 13, 2013, REPRODUCTION, Vol. 4, pp. ISSN: 2046-1690. DOI: 10.9754/journal.wmc.2013.004252; http://www.webmedcentral.com/article_view/4252. ISSN: 2046-1690.
  121. Effect of antioxidants (vitamin C, E and turmeric extract) on methimazole induced hypothyroidism in rats. Deshpande, U.R., Joseph, L.J., Patwardhan, U.N., Samuel, A.M. [ed.] K.S. Krishnan Marg. 6, New Delhi: National Institute of Science Communication and Information Resources, June 2002, Indian Journal of Experimental Biology, Vol. 40, pp. 735-738. ISSN: 0019-5189.
  122. Simon, Harvey and Zieve, David. Gallstones and gallbladder disease - Introduction. University of Maryland Medical Center Patient Education. [Online] August 26, 2012. [Cited: March 24, 2015.] http://www.umm.edu/patiented/articles/what_gallstones_gallbladder_disease_000010_1.htm.
  123. Zamani, Farhad. Gallstone Disease. Research Center, Iran University of Medical Sciences. Tehran: Iranian Association of Gastroenterology and Hepatology, 2010. pp. 1-39.
  124. Herrine, Steven K., Navarro, Victor J. and Rubin, Raphael. The Liver and Biliary System. [ed.] Raphael Rubin, David S. Strayer and Emanuel Rubin. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 6. Philadelphia: Wolters Kluwer: Lippincott Williams & Wilkins, 2012, 14, pp. 677-736. ISBN: 978-1-60547-968-2.
  125. Caldecott, Todd. Ayurveda: The Divine Science of Life. s.l.: Elsevier Health Sciences, 2006. ISBN: 978-0-7234-3410-8.
  126. Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rats: role of TGF-beta modulation and oxidative stress. Reyes-Gordillo, Karina, et al., et al. [ed.] Pascal Bousquet and Faiez Zannad. 4, Strasbourg; Nancy: Blackwell Publishing Ltd, August 2008, Fundamental & Clinical Pharmacology, Vol. 22, pp. 417-427. DOI: 10.1111/j.1472-8206.2008.00611.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1472-8206.2008.00611.x/abstract. eISSN: 1472-8206.
  127. Phaneuf, Holly. Herbs Demystified: A Scientist Explains How the Most Common Herbal Remedies Really Work. New York: Marlowe & Company; Avalon Publishing Group Inc., 2005. ISBN-13: 978-1-56924-408-1.
  128. Zhou, Jia ju, Xie, Guirong and Yan, Xinjian. Encyclopedia of Traditional Chinese Medicines: Molecular Structures, Pharmacological Activities, Natural Sources and Applications. Berlin: Springer-Verlag, 2011. Vols. 5: Isolated Compounds T-Z. ISBN: 978-3-642-16740-9.
  129. Dooley, James S. Gallstones and Benign Biliary Diseases. [ed.] James S. Dooley, et al., et al. Sherlock's Diseases of the Liver and Biliary System. Oxford: Blackwell Publishing Ltd., 2011, 12, pp. 257-293. ISBN: 978-1-4051-3489-7.
  130. Hereditary liver disease: Gallstones. Wittenburg, Henning. [ed.] Ernst J. Kuipers. 5, Rotterdam: Elsevier Inc., October 2010, Best Practice & Research Clinical Gastroenterology, Vol. 24, pp. 747-756. DOI: 10.1016/j.bpg.2010.07.004; http://www.bpgastro.com/article/S1521-6918(10)00083-1/abstract. ISSN: 1521-6918.
  131. Phelps, Kerryn. Gastroenterology. [ed.] Kerryn Phelps and Craig Hassed. General Practice: The Integrative Approach. Chatswood: Elsevier Australia, 2010, 30. ISBN-13: 978-0-72-953804-6.
  132. Medeiros, Robert E., Wildman, C. Digestion and Absorption. Advanced Human Nutrition. 2. Sudbury: Jones & Bartlett Publishers, 2011, 2nd, pp. 33-53. ISBN: 978-0-7637-8039-5.
  133. Guyton, Arthur C. and Hall, John E. Secretory Functions of the Alimentary Tract. Textbook of Medical Physiology. 11. Philadelphia: Elsevier Inc., 2006, 64, pp. 791-807. ISBN: 0-7216-0240-1.
  134. --. General Principles of Gastrointestinal Function--Motility, Nervous Control, and Blood Circulation. Textbook of Medical Physiology. 11. Philadelphia: Elsevier Inc., 2006, 62, pp. 771-780. ISBN: 0-7216-0240-1.
  135. Biliary microlithiasis, sludge, crystals, microcrystallization, and usefulness of assessment of nucleation time. Abeysuriya, Vasitha, Deen, Kemal I. and Navarathne, Navarathne M. M. [ed.] Shu-Sen Zheng. 3, Hangzhou: First Affiliated Hospital, Zhejiang University School of Medicine, June 15, 2010, Hepatobiliary & Pancreatic Diseases International, Vol. 9, pp. 248-253. ISSN: 1499-3872.
  136. Sephel, Gregory C. and Davidson, Jeffrey M. Repair, Regeneration and Fibrosis. [ed.] Raphael Rubin, David S. Strayer and Emanuel Rubin. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 6. Philadelphia: Wolters Kluwer: Lippincott Williams & Wilkins, 2012, 3, pp. 83-114. ISBN: 978-1-60547-968-2.
  137. Harris, Bob. Phytotherapeutic Uses of Essential Oils. [ed.] K. Hüsnü Can Baṣer and Gerhard Buchbauer. Handbook of Essential Oils: Science, Technology, and Applications. Boca Raton: CRC Press: Taylor and Francis Group, LLC, 2010, 11, pp. 315-353. ISBN: 978-1-4200-6315-8.
  138. Chang, Hson-Mou and But, Paul Pui-Hay. Jianghuang.Pharmacology and Applications of Chinese Materia Medica. Singapore: World Scientific Publishing Co. Ptc. Ltd., 2001, Vol. 2, pp. 937-941. ISBN: 981-02-3694-8.
  139. Krzyzanowska, Justyna, Czubacka, Anna and Oleszek, Wieslaw. Dietary Phytochemicals and Human Health. [ed.] Maria Teresa Giardi, Giuseppina Rea and Bruno Berra. Bio-Farms for Nutraceuticals: Functional Food and Safety Control by Biosensors. Austin: Landes Bioscience and Springer Science+Business Media, LLC, 2010, 7, pp. 74-98. ISBN: 978-1-4419-7346-7.
  140. Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis. Payne, Claire M., Crowley-Skillicorn, Cheray, Bernstein, Carol, Holubec, Hana and Bernstein, Harris. [ed.] Ronnie Fass. Los Angeles: Dove Medical Press, May 3, 2011, Clinical and Experimental Gastroenterology, Vol. 4, pp. 75-119. DOI: 10.2147/CEG.S17114; http://www.dovepress.com/molecular-and-cellular-pathways-associated-with-chromosome-1p-deletion-peer-reviewed-article-CEG. ISSN: 1178-7023.
  141. Murray, Michael T. and Pizzorno, Joseph E. Curcuma longa (turmeric). Textbook of Natural Medicine. 2. Edinburgh: Harcourt Publishers Limited: Churchill Livingstone, 1999, Vol. Pharmacology of natural medicines, 80, pp. 690-694. ISBN: 0-443-05945-4.
  142. Turmeric: A Herbal and Traditional Medicine. Bhowmik, Debjit, et al., et al. [ed.] Eno E. Ebenso. 2, Mmabatho: Scholars Research Library, 2009, Archives of Applied Science Research, Vol. 1, pp. 86-108. ISSN: 0975-508X.
  143. Illinois Department of Public Health. Clostridium perfringens. Emergency Preparedness - Bioterrorism. [Online] [Cited: March 9, 2015.] http://www.idph.state.il.us/Bioterrorism/factsheets/clostridium.htm.
  144. Turmeric and curcumin: Biological actions and medicinal applications. Chattopadhyay, Ishita, et al., et al. [ed.] P. Balaram. 1, Bangalore: Indian Academy of Sciences, July 10, 2004, Current Science, Vol. 87, pp. 44-53. ISSN: 0011-3891.
  145. Braun, Lesley and Cohen, Marc. Herbs & Natural Supplements: An Evidence-Based Guide. Marrickville: Elsevier Australia, 2007. ISBN-13: 978-0-7295-3796-4.
  146. Herbal medicinal products for non-ulcer dyspepsia. Coon, J. Thompson and Ernst, E. [ed.] Roy E. Pounder and Walter L. Peterson. 10, London; Dallas: John Wiley & Sons Ltd, October 2002, Alimentary Pharmacology & Therapeutics, Vol. 16, pp. 1689-1699. DOI: 10.1046/j.1365-2036.2002.01339.x; http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2036.2002.01339.x/abstract. eISSN: 1365-2036.
  147. Pharmacological Potential of the Plants Used in Treatment of Piles - A Review. Lather, A., et al., et al. 1, Jaipur: Meera Shikshan Sansthan, January 2011, Journal of Natura Conscientia, Vol. 2, pp. 255-265. ISSN: 2229-4295.
  148. Comparative clinical evaluation of Kshara Sutra ligation and hemorrhoidectomy in Arsha (hemorrhoids). Gupta, Meva Lal, Gupta, S.K. and Bhuyan, Chaturbhuja. [ed.] M.S. Baghel. 2, Gujarat: Institute for Post Graduate Teaching & Research in Ayurveda, Gujarat Ayurved University, Apr-Jun 2011, International Quarterly Journal of Research in Ayurveda, Vol. 32, pp. 225-229. DOI: 10.4103/0974-8520.92591; http://www.ayujournal.org/article.asp?issn=0974-8520;year=2011;volume=32;issue=2;spage=225;epage=229;aulast=Gupta. ISSN: 0974-8520.
  149. Thornton, Scott C., Perry, Kyle R. and Rosh, Adam J. Hemorrhoids Treatment & Management: Overview, Treatment. Medscape Reference: Drugs, Diseases & Procedures. [Online] November 3, 2014. [Cited: January 13, 2015.] http://emedicine.medscape.com/article/775407-overview#showall.
  150. Bodenhamer, William. A Theoretical and Practical Treatise on the Hemorrhoidal Disease: Giving Its History, Nature, Causes, Pathology, Diagnosis and Treatment. New York: William Wood & Company, 1884.
  151. WebMD, LLC.; David T. Derrer. Hemorrhoid Surgery. WebMD. [Online] July 27, 2014. [Cited: March 24, 2015.] http://www.webmd.com/a-to-z-guides/surgery-treat-hemorrhoids.
  152. Do dietary spices impair the patient-reported outcomes for stapled hemorrhoidopexy? A randomized controlled study. Agarwal, Brij B. [ed.] Alfred Cuschieri and Mark A. Talamini. 5, Dundee, San Diego: Springer-Verlag, May 2011, Surgical Endoscopy, Vol. 25, pp. 1535-1540. DOI: 10.1007/s00464-010-1431-1; http://link.springer.com/article/10.1007%2Fs00464-010-1431-1. ISSN: 0930-2794.
  153. Goldman, Alan L. The Evaluation of Rectal Pain and Bleeding and The Non-Operative Treatment of Hemorrhoids and Anal Fissures. Atlanta: Emory University: The Center for Colorectal Health, 2007.
  154. Red Hot Chili Pepper and Hemorrhoids: The Explosion of a Myth: Results of a Prospective, Randomized, Placebo-Controlled, Crossover Trial. Altomare, Donato F., et al., et al. [ed.] Robert D. Madoff. 7, Minneapolis: Springer-Verlag, July 1, 2006, Diseases of the Colon & Rectum, Vol. 49, pp. 1018-1023. DOI: 10.1007/s10350-006-0532-3; http://journals.lww.com/dcrjournal/pages/articleviewer.aspx?year=2006&issue=49070&article=00010&type=abstract. ISSN: 0012-3706.
  155. Antimicrobial Potential of Polyherbo-Mineral Formulation Jatyadi Taila - A Review. Baljinder, Singh, et al., et al. [ed.] Shalini Sharma. 1, Karnataka: Moksha Publishing House, Jan-Feb 2011, International Journal of Research in Ayurveda and Pharmacy, Vol. 2, p. 151-156. ISSN: 2229-3566.
  156. Lad, Vasant. The Complete Book of Ayurvedic Home Remedies. New York: Random House, Inc.: Three Rivers Press, 1998. ISBN: 0-609-80286-0.
  157. Khalsa, Karta Purkh Singh and Tierra, Michael. Ayurvedic Materia Medica. The Way of Ayurvedic Herbs: The Most Complete Guide to Natural Healing and Health with Traditional Ayurvedic Herbalism. 1. Twin Lakes: Lotus Press, 2008, 8, pp. 75-198. ISBN: 978-0-9409-8598-8.
  158. Curcumin for Inflammatory Bowel Disease: A Review of Human Studies. Taylor, Rebecca A. and Leonard, Mandy C. [ed.] Kathleen A. Head. 2, Napa: Alternative Medicine Review, LLC, June 2011, Alternative Medicine Review, Vol. 16, pp. 152-156. ISSN: 1089-5159.
  159. Examination of the Anti-Inflammatory, Antioxidant, and Xenobiotic-Inducing Potential of Broccoli Extract and Various Essential Oils during a Mild DSS-Induced Colitis in Rats. Mueller, Kristin, Blum, Nicole Michaela and Mueller, Andreas Stefan. [ed.] A. Amedei, A.K. Rishi and N. Senninger. Article ID 710856, Halle (Saale): Hindawi Publishing Corporation, January 20, 2013, ISRN Gastroenterology, Vol. 2013, pp. 1-14. DOI: 10.1155/2013/710856; http://www.hindawi.com/journals/isrn/2013/710856/. ISSN: 2090-4398.
  160. Chronic Inflammation and Cancer: The Role of the Mitochondria. Kamp, David W., Shacter, Emily and Weitzman, Sigmund A. [ed.] James O. Armitage, et al., et al. 5, London: UBM Medica LLC, April 30, 2011, Oncology, Vol. 25, pp. 400-10, 413. ISSN: 0890-9091.
  161. Abreu, Maria T., Fukata, Masayuki and Breglio, Keith. iInnate Immunity and its Implications on Pathogenesis of Inflammatory Bowel Disease. [ed.] Stephan R. Targan, Fergus Shanahan and Loren C. Karp. Inflammatory Bowel Disease: Translating Basic Science Into Clinical Practice. West Sussex: John Wiley and Sons: Blackwell Publishing Ltd, 2010, 7, pp. 64-81. ISBN: 978-1-4051-57254.
  162. Mayo Clinic staff. Ulcerative colitis: Risk factors. Mayo Foundation for Medical Education and Research. [Online] September 9, 2014. [Cited: March 24, 2015.] http://www.mayoclinic.com/health/ulcerative-colitis/DS00598/DSECTION=risk-factors.
  163. Risk Factors for Inflammatory Bowel Disease in the General Population. Rodríguez, L.A. García, et al., et al. [ed.] Roy E. Pounder and Walter L. Peterson. 4, London; Dallas: John Wiley & Sons, Inc., August 23, 2005, Alimentary Pharmacology & Therapeutics, Vol. 22, pp. 309-315. DOI: 10.1111/j.1365-2036.2005.02564.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2005.02564.x/full. eISSN: 1365-2036.
  164. Bernstein, Charles N. Epidemiology of Inflammatory Bowel Disease: the Shifting Landscape. [ed.] Stephan R. Targan, Fergus Shanahan and Loren C. Karp. Inflammatory Bowel Disease: Translating Basic Science Into Clinical Practice. West Sussex: John Wiley and Sons: Blackwell Publishing Ltd, 2010, 3, pp. 9-15. ISBN: 978-1-4051-57254.
  165. Mayo Clinic staff. Inflammatory bowel disease (IBD): Risk factors; Treatments and drugs. Mayo Foundation for Medical Education and Research. [Online] February 18, 2015. [Cited: March 24, 2015.] http://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/basics/treatment/con-20034908.
  166. Therapeutic potential of curcumin in gastrointestinal diseases. Rajasekaran, Sigrid A. [ed.] Lian-Sheng Ma. 1, Beijing: Baishideng Publishing Group Co., Limited, February 15, 2011, World Journal of Gastroenterology, Vol. 2, pp. 1-14. DOI: 10.4291/wjgp.v2.i1.1; http://www.wjgnet.com/2150-5330/full/v2/i1/1.htm. ISSN: 1007-9327.
  167. Curcumin Protects Intestinal Mucosal Barrier Function of Rat Enteritis via Activation of MKP-1 and Attenuation of p38 and NF-κB Activation. Song, Wei-Bing, et al., et al. [ed.] Stefan Bereswill. 9, Berlin: Public Library of Science, September 24, 2010, PLoS One, Vol. 5, p. e12969. DOI: 10.1371/journal.pone.0012969; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012969. ISSN: 1932-6203.
  168. Rogler, Gerhard. Non-targeted Therapeutics for Inflammatory Bowel Diseases. [ed.] Stephan R. Targan, Fergus Shanahan and Loren C. Karp. Inflammatory Bowel Disease: Translating Basic Science Into Clinical Practice. West Sussex: John Wiley and Sons: Blackwell Publishing Ltd, 2010, 24. ISBN: 978-1-4051-57254.
  169. Binion, David G. and Rafiee, Parvaneh. Inflammatory Bowel Disease Microcirculation and Diversion, Diverticular and Other Non-infectious Colitides. [ed.] Stephan R. Targan, Fergus Shanahan and Loren C. Karp. Inflammatory Bowel Disease: Translating Basic Science Into Clinical Practice. West Sussex: John Wiley and Sons: Blackwell Publishing Ltd, 2010, 42, pp. 609-618. ISBN: 978-1-4051-57254.
  170. Langmead, Louise and Rampton, David S. Complementary Medicine. [ed.] Stephan R. Targan, Fergus Shanahan and Loren C. Karp. Inflammatory Bowel Disease: Translating Basic Science Into Clinical Practice. West Sussex: John Wiley and Sons: Blackwell Publishing Ltd, 2010, 48, pp. 693-704. ISBN: 978-1-4051-57254.
  171. Elson, Charles O. and Weaver, Casey T.  In Vivo Models of Inflammatory Bowel Disease. [ed.] Stephan R. Targan, Fergus Shanahan and Loren C. Karp. Inflammatory Bowel Disease: Translating Basic Science Into Clinical Practice. West Sussex: John Wiley and Sons: Blackwell Publishing Ltd, 2010, 5, pp. 25-51. ISBN: 978-1-4051-57254.
  172. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Gupta, Subash C., et al., et al. [ed.] Avraham Raz and Kenneth V. Honn. 3, Detroit: Springer Science+Business Media, LLC, September 1, 2010, Cancer and Metastasis Reviews, Vol. 29, pp. 405-434. DOI: 10.1007/s10555-010-9235-2; http://link.springer.com/article/10.1007%2Fs10555-010-9235-2. eISSN: 1573-7233.
  173. Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells. Park, Sun Young, et al., et al. [ed.] C. Fred Fox, Gary S. Stein and Max M. Burger. 12, Los Angeles; Burlington; Basel: Wiley Periodicals, Inc., December 2012, Journal of Cellular Biochemistry, Vol. 113, pp. 3653-3662. http://onlinelibrary.wiley.com/doi/10.1002/jcb.24238/abstract. eISSN: 1097-4644.
  174. Molecular targets of dietary agents for prevention and therapy of cancer. Aggarwal, Bharat B. and Shishodia, Shishir. [ed.] Sam J. Enna. 10, Kansas City: Elsevier Inc., May 14, 2006, Biochemical Pharmacology, Vol. 71, pp. 1397-1421. DOI: 10.1016/j.bcp.2006.02.009; http://www.sciencedirect.com/science/article/pii/S0006295206000955. ISSN: 0006-2952.
  175. Management of Irritable Bowel Syndrome (IBS) in Adults: Conventional and Complementary/Alternative Approaches. Yoon, Saunjoo L., et al., et al.  [ed.] Kathleen A. Head. 2, Napa: Thorne Research, Inc., June 2011, Alternative Medicine Review, Vol. 16. ISSN: 1089-5159.
  176. Dave, Jason Sailesh. Inflammatory Bowel Disease & Irritable Bowel Syndrome. [ed.] Thomas G. Guilliams. The Standard: A Review of Natural & Nutraceutical Therapies for Clinical Practice. 2010, Vol. 10, 1, pp. 4-19.
  177. Curcumin Regulates Expression and Activity of Matrix Metalloproteinases 9 and 2 during Prevention and Healing of Indomethacin-induced Gastric Ulcer. Swarnakar, Snehasikta, et al., et al. [ed.] Herbert Tabor. 10, Rockville: American Society for Biochemistry and Molecular Biology, March 11, 2005, The Journal of Biological Chemistry, Vol. 280, pp. 9409-9415. DOI: 10.1074/jbc.M413398200;http://www.jbc.org/content/280/10/9409. ISSN: 0021-9258.
  178. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure?. Di Mario, Francesco, et al., et al. [ed.] David Y Graham. 3, Houston: John Wiley & Sons, Inc., June 2007, Helicobacter, Vol. 12, pp. 238-243. DOI: 10.1111/j.1523-5378.2007.00497.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1523-5378.2007.00497.x/abstract. ISSN: 1083-4389.
  179. Hazardous Substances Data Bank. Omeprazole. TOXNET Toxicology Data Network. [Online] January 31, 2005. [Cited: March 24, 2015.] http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~YDrZaG:1. CASRN: 73590-58-6.
  180. Anand, B.S. Peptic Ulcer Disease. Medscape Reference: Drugs, Diseases & Procedures. [Online] January 9, 2015. [Cited: March 24, 2015.] http://emedicine.medscape.com/article/181753-overview#showall.
  181. Effect of curcumin on Helicobacter pylori biofilm formation. Pattiyathanee, Panan, Vilaichone, Ratha-korn and Chaichanawongsaroj, Nuntaree. [ed.] George Nkem Ude. 19, Bowie: African Journals Online, October 9, 2009, African Journal of Biotechnology, Vol. 8, pp. 5106-5115. ISSN: 1684-5315.
  182. An ulcer negative for Helicobacter pylori and nonsteroidal anti-inflammatory drugs? Consider herbal treatment as the culprit!. Miller, Seth B., et al., et al. [ed.] Kazuaki Chayama. 4, Hiroshima: Springer Japan, August 1, 2009, Clinical Journal of Gastroenterology, Vol. 2, pp. 266-267. DOI: 10.1007/s12328-009-0088-6; http://link.springer.com/article/10.1007%2Fs12328-009-0088-6. ISSN: 1865-7257.
  183. Curcuma longa Extract Protects against Gastric Ulcers by Blocking H2 Histamine Receptors. Kim, Dong-Chan, et al., et al. [ed.] Naoto Oku. 12, Shizuoka: The Pharmaceutical Society of Japan, December 2005, Biological & Pharmaceutical Bulletin, Vol. 28, pp. 2220-4. DOI: 10.1248/bpb.28.2220; https://www.jstage.jst.go.jp/article/bpb/28/12/28_12_2220/_article. ISSN: 0918-6158.
  184. Indigestion (Ajirna). [book auth.] Shankar K. Mitra and Paramesh R. Rangesh. [ed.] Lakshmi C. Mishra. Scientific Basis for Ayurvedic Therapies. Boca Raton: CRC Press LLC, 2004, 17, pp. 307-322. ISBN: 0-8493-1366-X.
  185. Natural products in treatment of ulcerative colitis and peptic ulcer. Awaad, Amani S., El-Meligy, Reham M. and Soliman, Gamal A. [ed.] Abdullah M. AlMayouf. 1, Riyadh: Elsevier B.V.: King Saud University, January 2013, Journal of Saudi Chemical Society, Vol. 17, pp. 101-124. DOI: 10.1016/j.jscs.2012.03.002; http://www.sciencedirect.com/science/article/pii/S1319610312000397. ISSN: 1319-6103.
  186. Effects of Turmeric in Peptic Ulcer and Helicobacter pylori. Aljamal, Abdulrahim. [ed.] Muhammad Sohail. 3, s.l.: Medwell Journals, 2011, Plant Sciences Research, Vol. 3, pp. 25-28. ISSN: 1995-476X.
  187. Phase II Clinical Trial on Effect of the Long Turmeric (Curcuma Longa Linn) on Healing of Peptic Ulcer. Prucksunand, Chaweewan, et al., et al. [ed.] Suvanee Supavej. 1, Bangkok: SEAMEO Regional Tropical Medicine and Public Health Network, March 2001, The Southeast Asian Journal of Tropical Medicine and Public Health, Vol. 32, pp. 208-215. ISSN: 0125-1562.
  188. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients. Koosirirat, Chucart, et al., et al. [ed.] J.E. Talmadge. 7, Omaha: Elsevier B.V., July 2010, International Immunopharmacology, Vol. 10, pp. 815-818. DOI: 10.1016/j.intimp.2010.04.021; http://www.sciencedirect.com/science/article/pii/S1567576910001359. ISSN: 1567-5769.
  189. The effects of a traditional drug, turmeric (Curcuma longa), and placebo on the healing of duodenal ulcer. Van Dau, N., et al., et al. [ed.] N.R. Farnsworth and H. Wagner. 1, Chicago, Munich: Elsevier GmbH: Gusav Fischer Verlag, March 1998, Phytomedicine, Vol. 5, pp. 29-34. DOI: 10.1016/S0944-7113(98)80056-1; http://www.sciencedirect.com/science/article/pii/S0944711398800561. ISSN: 0944-7113.
  190. Natural Medicines Comprehensive Database Consumer Version Therapeutic Research Faculty. Lactoferrin. WebMD: Find a Vitamin or Supplement. [Online] 2009. [Cited: March 25, 2015.] http://www.webmd.com/vitamins-supplements/ingredientmono-49-LACTOFERRIN.aspx?activeIngredientId=49&activeIngredientName=LACTOFERRIN.
  191. Medicines Comprehensive Database Consumer Version Therapeutic Research Faculty. N-Acetyl Cysteine. WebMD: Find a Vitamin or Supplement. [Online] 2009. [Cited: March 25, 2015.] http://www.webmd.com/vitamins-supplements/ingredientmono-1018-N-ACETYL%20CYSTEINE.aspx?activeIngredientId=1018&activeIngredientName=N-ACETYL%20CYSTEINE.
  192. Wynn, Susan G. and Fougère, Barbara. Veterinary Herbal Medicine. St. Louis: Elsevier Health Sciences, 2007. ISBN-13: 978-0-323-02998-8.
  193. Cardiovascular Protection by Curcumin: Molecular Aspects. Kapakos, Georgia, Youreva, Viktoria and Srivastava, Ashok K. [ed.] S.C. Sharma. New Delhi: National Institute of Science Communication and Information Resources, October 2012, Indian Journal of Biochemistry & Biophysics, Vol. 49, pp. 306-315. ISSN: 0301-1208.
  194. Protective Effect of Curcumin on Pulmonary and Cardiovascular Effects Induced by Repeated Exposure to Diesel Exhaust Particles in Mice. Nemmar, Abderrahim, Subramaniyan, Deepa and Ali, Badreldin H. [ed.] Mauricio Rojas. 6, s.l.: Public Library of Science, June 22, 2012, PLoS One, Vol. 7, p. e39554. DOI: 10.1371/journal.pone.0039554; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0039554. ISSN: 1932-6203.
  195. Nutraceutical in vascular complications-21st century perspective. Ali, Kazi Monjur and Ghosh, Debidas. [ed.] Shyamapada Paul. 1, West Bengal: Rural Research Institute of Physiology & Applied Nutrition, 2012, Journal of Community Nutrition & Health, Vol. 1, pp. 30-38. ISSN: 2278-7542.
  196. Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women: pilot study. Sugawara, Jun, et al., et al. [ed.] Michael H. Alderman. 6, New York: Nature Publishing Group, June 2012, American Journal of Hypertension, Vol. 25, pp. 651-656. DOI: 10.1038/ajh.2012.24; http://ajh.oxfordjournals.org/content/25/6/651. ISSN: 0895-7061.
  197. Curcumin maintains cardiac and mitochondrial function in chronic kidney disease. Correa, Francisco, et al., et al. [ed.] Kelvin Davies. Los Angeles: Elsevier Inc., August 2013, Free Radical Biology and Medicine, Vol. 61, pp. 119-129. DOI: 10.1016/j.freeradbiomed.2013.03.017; http://www.sciencedirect.com/science/article/pii/S0891584913001226. ISSN: 0891-5849.
  198. Shishodia, Shishir, Singh, Tulika and Chaturvedi, Madan M. Modulation of Transcription Factors by Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 127-148. ISBN-13: 978-0-387-46400-8.
  199. Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Prakash, Prem, et al., et al. [ed.] Charles Francis and Per Morten Sandset. 2, Rochester; Oslo: European Thrombosis Research Organisation, February 2011, Thrombosis Research, Vol. 127, pp. 111-118. DOI: 10.1016/j.thromres.2010.11.007; http://www.thrombosisresearch.com/article/S0049-3848(10)00603-1/abstract. ISSN: 0049-3848.
  200. Protective effect of curcumin against cardiac dysfunction in sepsis rats. Yang, Cheng, et al., et al. [ed.] John M. Pezzuto. 4, London: Informa Healthcare, April 2013, Pharmaceutical Biology, Vol. 51, pp. 482-487. DOI: 10.3109/13880209.2012.742116; http://informahealthcare.com/doi/abs/10.3109/13880209.2012.742116. ISSN: 1388-0209.
  201. Large Elastic Artery Stiffness with Aging: Novel Translational Mechanisms and Interventions. Fleenor, Bradley S. [ed.] Kunlin Jin, Ashok K. Shetty and David A. Greenberg. 2, Fort Worth; Temple; Novato: International Society on Aging and Disease, December 11, 2012, Aging and Disease, Vol. 4, pp. 76-83. ISSN: 2152-5250.
  202. The International Heart Institute Foundation. Coronary Artery Disease. The International Heart Institute of Montana Foundation. [Online] December 2009. [Cited: March 25, 2015.] http://www.ihimontanafoundation.org/Heart_Information/Heart_Conditions/Coronary_Artery_Disease.
  203. --. High Blood Pressure. The International Heart Institute of Montana Foundation. [Online] December 2009. [Cited: March 25, 2015.] http://www.ihimontanafoundation.org/Heart_Information/Heart_Conditions/High_Blood_Pressure.
  204. Role of Dietary Advanced Glycation End Products in Diabetes Mellitus. Luevano-Contreras, Claudia, Garay-Sevilla, Ma. Eugenia and Chapman-Novakofski, Karen. [ed.] Bruce Buehler. 1, Omaha: SAGE Publications, January 2013, Journal of Evidence-Based Complementary and Alternative Medicine, Vol. 18, pp. 50-66. DOI: 10.1177/2156587212460054; http://chp.sagepub.com/content/18/1/50. ISSN: 2156-5872.
  205. Vasorelaxant Effect induced by Alpha-Terpineol in Superior Mesenteric Artery of l-Name-Induced Hypertensive Rats. Sabino, C.K.B., Ferreira Filho, E.S., Moura, L.H.P., Ponte, M.P.T.R., Oliveira, R.C.M., Oliveira, A.P. Rio de Janeiro: Federação de Sociedades de Biologia Experimental, 2011. XXVI Reunião Anual da FeSBE. Resumo:02-041.
  206. University of Minnesota Medical School. U of M Medical School researchers find natural antioxidant can protect against cardiovascular disease. American Association for the Advancement of Science (AAAS): Eureka Alert! [Online] June 15, 2012. [Cited: March 25, 2015.] http://health.umn.edu/media/releases/GPx3/.
  207. Karunagaran, Devarajan, Joseph, Jeena and Kumar, Thankayyan R. Santhosh. Cell Growth Regulation. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 245-268. ISBN-13: 978-0-387-46400-8.
  208. Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease. Olofsson, Sven-Olof, Wiklund, Olov and Borén, Jan. [ed.] Roland Asmar. 4, Paris: Dove Medical Press Limited: International Society of Vascular Health, August 2007, Vascular Health and Risk Management, Vol. 3, pp. 491-502. ISSN: 1178-2048.
  209. Natural antihyperlipidemic agents: Current status and future perspectives. Ibrahim, Sabrin R.M., et al., et al. [ed.] T. Efferth. 3, Surrey: Inforesights Publishing, September 2013, Phytopharmacology, Vol. 4, pp. 492-531. ISSN: 2046-1194.
  210. Effects of Nutraceuticals and Botanicals on Macrophage Cholesterol Efflux: Implications for Atherosclerosis. Sotherden, Grace Megumi, et al., et al. [ed.] Ghazala Hafeez Rizwani. 2, Karachi: Lifescience Global, December 31, 2012, Journal of Nutritional Therapeutics, Vol. 1, pp. 96-106. DOI: 10.6000/1929-5634.2012.01.02.1; http://www.lifescienceglobal.com/journals/journal-of-nutritional-therapeutics/volume-1-number-2. eISSN: 1929-5634.
  211. Overcoming Multidrug Resistance in Human Cancer Cells by Natural Compounds. Nabekura, Tomohiro. [ed.] Florian Lang. 6, Basel: MDPI Publishing, May 28, 2010, Toxins, Vol. 2, pp. 1207-1224. DOI: 10.3390/toxins2061207; http://www.mdpi.com/2072-6651/2/6/1207. ISSN: 2072-6651.
  212. Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Shin, Su-Kyung, et al., et al. [ed.] Hans-Ulrich Humpf. 12, Weinheim: WILEY-VCH Verlag GmbH & Co., December 2011, Molecular Nutrition & Food Research, Vol. 55, pp. 1829-1840. DOI: 10.1002/mnfr.201100440; http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201100440/abstract. eISSN: 1613-4133.
  213. Novel Effects of a Single Administration of Ferulic Acid on the Regulation of Blood Pressure and the Hepatic Lipid Metabolic Profile in Stroke-Prone Spontaneously Hypertensive Rats. Ardiansyah, et al., et al. [ed.] James N. Seiber. 8, Davis: American Chemical Society, April 23, 2008, Journal of Agricultural and Food Chemistry, Vol. 56, pp. 2825-2830. DOI: 10.1021/jf072896y; http://pubs.acs.org/doi/abs/10.1021/jf072896y. ISSN: 0021-8561.
  214. Quercetin Reduces Blood Pressure in Hypertensive Subjects. Edwards, Randi L., et al., et al. [ed.] A. Catharine Ross. 11, University Park: American Society for Nutrition, November 2007, The Journal of Nutrition, Vol. 137, pp. 2405-2411. ISSN: 0022-3166.
  215. Vasorelaxant and Hypotensive Effects Induced by (-)-Borneol in Normotensive Rats. Silva-filho, J.C., et al., et al. Rio de Janeiro: Federação de Sociedades de Biologia Experimental, 2011. XXVI Reunião Anual da FeSBE. Resumo:02-042.
  216. Effect of Cloves and Turmeric on Hyperlipidemics. Balasasirekha, R. and Lakshmi, U.K. 2, Delhi: Kamla-Raj Enterprises, 2012, Journal of Human Ecology, Vol. 37, pp. 125-132. ISSN: 0970-9274.
  217. Oral Supplementation of Turmeric Decreases Proteinuria, Hematuria, and Systolic Blood Pressure in Patients Suffering From Relapsing or Refractory Lupus Nephritis: A Randomized and Placebo-controlled Study. Khajehdehi, Parviz, et al., et al. [ed.] Jerrilynn D. Burrowes and Christoph Wanner. 1, Brookville; Wüerzburg: Elsevier Inc.: National Kidney Foundation, Inc., January 2012, Journal of Renal Nutrition, Vol. 22, pp. 50-57. DOI: 10.1053/j.jrn.2011.03.002; http://www.jrnjournal.org/article/S1051-2276(11)00064-1/abstract. ISSN: 1051-2276.
  218. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. DiSilvestro, Robert A, et al., et al. [ed.] Nehme Gabriel. 79, Leesburg: BioMed Central Ltd., September 26, 2012, Nutrition Journal, Vol. 11. DOI: 10.1186/1475-2891-11-79; http://www.nutritionj.com/content/11/1/79. ISSN: 1475-2891.
  219. Myeloperoxidase in the diagnosis of acute coronary syndromes: The importance of spectrum. Peacock, W. Frank, et al., et al. [ed.] Robert M. Califf. 5, Durham: Mosby, Inc., November 2011, American Heart Journal, Vol. 162, pp. 893-899. DOI: 10.1016/j.ahj.2011.08.017; http://www.ahjonline.com/article/S0002-8703(11)00635-1/abstract. ISSN: 0002-8703.
  220. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Soni, K.B. and Kuttan, R. [ed.] K.K. Deepak. 4, Delhi: Association of Physiologists and Pharmacologists of India, October 1992, Indian Journal of Physiology and Pharmacology, Vol. 36, pp. 273-275. ISSN: 0019-5499.
  221. Metametrix Clinical Laboratory. Women's Health Profile Guide. 2007. pp. 1-8.
  222. Cerner Multum, Inc. Atorvastatin. Drugs.com. [Online] March 21, 2012. [Cited: March 25, 2015.] http://www.drugs.com/atorvastatin.html.
  223. Effects of Supplementation with Curcuminoids on Dyslipidemia in Obese Patients: A Randomized Crossover Trial. Mohammadi, Akram, et al., et al. [ed.] Elizabeth M. Williamson, et al., et al. 3, Reading; Naples; Seoul; Charleston: John Wiley & Sons, Ltd., May 21, 2012, Phytotherapy Research, Vol. 27, pp. 374-379. DOI: 10.1002/ptr.4715; http://onlinelibrary.wiley.com/doi/10.1002/ptr.4715/abstract. eISSN: 1099-1573.
  224. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Heymans, Stephane, et al., et al. [ed.] Dirk J. van Veldhuisen. 2, Groningen: Oxford University Press: European Society of Cardiology, February 2009, European Journal of Heart Failure, Vol. 11, pp. 119-129. DOI: 10.1093/eurjhf/hfn043; http://onlinelibrary.wiley.com/doi/10.1093/eurjhf/hfn043/abstract. ISSN: 1388-9842.
  225. AHA Statistical Update. Go, Alan S., et al., et al. [ed.] Joseph Loscalzo. 1, Boston: American Heart Association, Inc., January 1, 2013, Circulation, Vol. 127, pp. e6-e245. DOI: 10.1161/CIR.0b013e31828124ad; http://circ.ahajournals.org/content/127/1/e6. ISSN: 0009-7322.
  226. Rodella, Luigi Fabrizio and Favero, Gaia. Atherosclerosis and Current Anti-Oxidant Strategies for Atheroprotection. [ed.] Rita Rezzani. Current Trends in Atherogenesis. Rijeka: InTech, 2013, 1, pp. 1-26. ISBN: 978-953-51-1011-8.
  227. Curcumin Improves Hemodynamic Status and Attenuates Arterial Remodeling in L-NAME-Induced Hypertensive Rats. Boonla, Orachorn, et al., et al. Bangkok: Journal of Physiological and Biomedical Sciences, 2012. 41st Annual Scientific Meeting of The Physiological Society of Thailand. Vol. 25, p. 38. O-04.
  228. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. Morimoto, Tatsuya, et al., et al. [ed.] Howard Rockman. 3, Durham: American Society for Clinical Investigation, March 3, 2008, The Journal of Clinical Investigation, Vol. 118, pp. 868–878. DOI: 10.1172/JCI33160; http://www.jci.org/articles/view/33160. ISSN: 0021-9738.
  229. Friedlander, Jodi and Bauman, Edward. Cardiovascular Disease: New Assessments, New Recommendations. Holistic Nutrition and Culinary Arts. Penngrove: Bauman College, 2008. pp. 1-24.
  230. Harvard Medical School. The Healthy Heart: Preventing, detecting, and treating coronary artery disease. Harvard Health Newsweek. 2009.
  231. The Sonodynamic Effect of Curcumin on THP-1 Cell-Derived Macrophages. Wang, Fengping, et al., et al. [ed.] Leandro Machado Rocha. Article ID 737264, Harbin: Hindawi Publishing Corporation, 2013, BioMed Research International, Vol. 2013, pp. 1-9. DOI: 10.1155/2013/737264; http://www.hindawi.com/journals/bmri/2013/737264/. eISSN: 2314-6141.
  232. Curcumin Suppresses Gelatinase B Mediated Norepinephrine Induced Stress in H9c2 Cardiomyocytes. Kohli, Shrey, et al., et al. [ed.] Effie C. Tsilibary. 10, Demokritos: Public Library of Science, October 7, 2013, PLoS One, Vol. 8, p. e76519. DOI: 10.1371/journal.pone.0076519; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076519. eISSN: 1932-6203.
  233. Miriyala, Sumitra, Panchatcharam, Manikandan and Rengarajulu, Puvanakrishnan. Cardioprotective Effects of Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 359-378. ISBN-13: 978-0-387-46400-8.
  234. National Toxicology Program. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1). U.S. Department of Health and Human Services. [Online] August 1993. [Cited: February 24, 2015.] http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr427.pdf. NTP TR 427; NIH Publication No. 93-3158.
  235. Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels. Dierkes, Jutta, Luley, Claus and Westphal, Sabine. [ed.] Roland Asmar. 1, Paris: Dove Medical Press Limited, February 2007, Vascular Health and Risk Management, Vol. 3, pp. 99-108. ISSN: 1178-2048.
  236. Heart Disease: Symptoms, Diagnosis, Treatment. National Institutes of Health; Friends of the National Library of Medicine. [ed.] Donald West King, et al., et al. 1, Bethesda: Krames StayWell, Winter 2009, NIH MedlinePlus, Vol. 4, pp. 25-27. ISSN: 1937-4712.
  237. Irbesartan and Lipoic Acid Improve Endothelial Function and Reduce Markers of Inflammation in the Metabolic Syndrome: Results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) Study. Sola, Srikanth, et al., et al. [ed.] Joseph Loscalzo. 3, Boston: American Heart Association, Inc., January 25, 2005, Circulation, Vol. 111, pp. 343-348. DOI: 10.1161/01.CIR.0000153272.48711.B9; http://circ.ahajournals.org/content/111/3/343. ISSN: 0009-7322.
  238. Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms. Kalyanaraman, Balaraman. [ed.] V.M. Darley-Usmar and T. Grune. 1, Birmingham; Jena: Elsevier B.V., 2013, Redox Biology, Vol. 1, pp. 244-257. ISSN: 2213-2317.
  239. Houston, Mark C. The Role of Vascular Biology, Nutrition, and Nutraceuticals in the Prevention and Treatment of Hypertension and Cardiovascular Disease. San Diego: Scripps Health, 2012. pp. 1-28.
  240. Effect of Tetrahydrocurcumin on Aortic Stiffening in Mice Exposed to Cadmium. Donpunha, Wanida, et al., et al. Bangkok: Journal of Physiological and Biomedical Sciences, 2012. 41st Annual Scientific Meeting of The Physiological Society of Thailand. Vol. 25, p. 36. O-02.
  241. QTc modulation by grapefruit juice in humans: HERG block by flavonoids as possible pharmacological basis. Karle, C., et al., et al. s.l.: European Society of Cardiology, 2003. ESC Congress 2003: New insights into traditional and novel anti-arrhythmic drugs. p. 719. 3695.
  242. SREBP2 mediates the modulation of intestinal NPC1L1 expression by curcumin. Kumar, Pradeep, et al., et al. [ed.] Kay Lund. 1, Chapel Hill: The American Physiological Society, July 1, 2011, American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 301, pp. G148-G155. DOI: 10.1152/ajpgi.00119.2011; http://ajpgi.physiology.org/content/301/1/G148. ISSN: 0193-1857.
  243. Curcuma oil ameliorates hyperlipidaemia and associated deleterious effects in golden Syrian hamsters. Singh, Vishal, et al., et al. [ed.] G.C. Burdge. 3, Southampton: Cambridge University Press, August 2013, British Journal of Nutrition, Vol. 110, pp. 437-446. DOI: http://dx.doi.org/10.1017/S0007114512005363; http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=8957513&fileId=S0007114512005363. ISSN: 0007-1145.
  244. Clifford, Mike N. and Brown, J.E. Dietary Flavonoids and Health — Broadening the Perspective. [ed.] Øyvind M. Andersen and Kenneth R. Markham. Flavonoids: Chemistry, Biochemistry, and Applications. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2006, 6, pp. 319-370. ISBN: 0-8493-2021-6.
  245. Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy. Luo, Honglin, Wong, Jerry and Wong, Brian. [ed.] Hans Michael Piper and David Garcia-Dorado. 2, Düsseldorf; Barcelona: Oxford University Press: European Society of Cardiology, July 3, 2009, Cardiovascular Research Spotlight Issue on: The Role of the Ubiquitin-Proteasome Pathway in Cardiovascular Disease, Vol. 85, pp. 347-356. DOI: 10.1093/cvr/cvp225; http://cardiovascres.oxfordjournals.org/content/85/2/347. ISSN: 0008-6363.
  246. Rodriguez-Cruz, Edwin and Ross, Robert D. Myocarditis, Viral. Medscape. [Online] August 29, 2013. [Cited: March 25, 2015.] http://emedicine.medscape.com/article/890740-overview.
  247. Mikdadi, Ghiath. Angioplasty and Stenting. s.l.: American College of Cardiology, 2011. pp. 1-7, CardioSmart.
  248. Curcumin increases vasodilatory effect of cilostazol in diabetic rat aorta. Nurullahoğlu-Atalik, K.E., et al., et al. [ed.] Ashok Agarwal. 2, New Delhi: CSIR-National Institute of Science Communication and Information Resources, February 2012, Indian Journal of Experimental Biology, Vol. 50, pp. 128-132. ISSN: 0019-5189.
  249. Oz, Mehmet. Heart Repair: Bypass or Angioplasty? When it comes to heart surgery options, it's never one size fits all. AARP The Magazine. Jan./Feb 2011.
  250. Anti-Inflammatory Polymeric Coatings for Implantable Biomaterials and Devices. Bridges, Amanda W. and Andrés J. García, Ph.D. [ed.] David C. Klonoff. 6, Burlingame: Diabetes Technology Society, November 2008, Journal of Diabetes Science and Technology, Vol. 2, pp. 984-994. ISSN: 1932-2968.
  251. Sefton, Michael V., Gemmell, Cynthia H. and Gorbet, Maud B. Nonthrombogenic Treatments and Strategies. [ed.] Buddy D. Ratner, et al., et al. Biomaterials Science. 3. Oxford: Academic Press: Elsevier Inc., 2013, Appendix E: Chapter II.5.2, pp. 1488-1509. ISBN: 978-0-12-374626-9.
  252. Curcumin (diferuloylmethane) delivery methods: A review. Angelo Azzi. 1, Boston: John Wiley & Sons, Inc.: International Union of Biochemistry and Molecular Biology, Inc., January/February 2013, Biofactors, Vol. 39, pp. 21-26. DOI: 10.1002/biof.1080; http://onlinelibrary.wiley.com/doi/10.1002/biof.1080/abstract. eISSN: 1872-8081.
  253. Preparation and blood compatibility of electrospun PLA/curcumin composite membranes. Chen, Yan, et al., et al. [ed.] Won Ho Jo. 10, Seoul: The Korean Fiber Society, December 2012, Fibers and Polymers, Vol. 13, pp. 1254-1258. DOI: 10.1007/s12221-012-1254-x; http://link.springer.com/article/10.1007%2Fs12221-012-1254-x. ISSN: 1229-9197.
  254. Demethoxycurcumin, a major active curcuminoid from Curcuma longa, suppresses balloon injury induced vascular smooth muscle cell migration and neointima formation: An in vitro and in vivo study. Sheu, Ming-Jyh, et al., et al. [ed.] Hans-Ulrich Humpf. 9, KGaA, Weinheim: WILEY-VCH Verlag GmbH & Co., September 2013, Molecular Nutrition & Food Research, Vol. 57, pp. 1586-1597. DOI: 10.1002/mnfr.201200462; http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201200462/abstract. eISSN: 1613-4133.
  255. Forming of Demethoxycurcumin Nanocrystallite-Chitosan Nanocarrier for Controlled Low Dose Cellular Release for Inhibition of the Migration of Vascular Smooth Muscle Cells. Wang, Yen-Jen, et al., et al. [ed.] Gordon L. Amidon. 8, Washington, D.C.: American Chemical Society, August 6, 2012, Molecular Pharmaceutics, Vol. 9, pp. 2268-2279. DOI: 10.1021/mp300150q; http://pubs.acs.org/doi/abs/10.1021/mp300150q. ISSN: 1543-8384.
  256. In vitro mutagenicity and blood compatibility of paclitaxel and curcumin in poly (dl-lactide-co-glicolide) films. Vieira, Iara Lucia Barbosa Fernandes, et al., et al. [ed.] Daniel Acosta, Frank A. Barile and Bas J. Blaauboer. 1, Cincinnati; Queens; Utrecht: Elsevier Ltd., February 2013, Toxicology in Vitro, Vol. 27, pp. 198-203. ISSN: 0887-2333.
  257. Natural wound healing and bioactive natural products. Tsala, David Emery, Amadou, Dawe and Habtemariam, Solomon. [ed.] T. Efferth. 3, Surrey: Inforesights Publishing, 2013, Phytopharmacology, Vol. 4, pp. 532-560. e2046-1194.
  258. Combined effect of PLGA and curcumin on wound healing activity. Chereddy, Kiran Kumar, et al., et al. [ed.] K. Park. 2, West Lafayette: Elsevier B.V., October 28, 2013, Journal of Controlled Release, Vol. 171, pp. 208-215. ISSN: 0168-3659.
  259. Proteins mediating collagen biosynthesis and accumulation in arterial repair: novel targets for anti-restenosis therapy. Osherov, Azriel B., et al., et al. [ed.] H. Michael Piper and David Garcia-Dorado. 1, Düsseldorf; Barcelona: Oxford University Press: European Society of Cardiology, July 1, 2011, Cardiovascular Research, Vol. 91, pp. 16-26. DOI: 10.1093/cvr/cvr012; http://cardiovascres.oxfordjournals.org/content/91/1/16.full. ISSN: 0008-6363.
  260. Dysregulation of the Ubiquitin-Proteasome System by Curcumin Suppresses Coxsackievirus B3 Replication. Si, Xiaoning, et al., et al. [ed.] Lynn W. Enquist. 7, Washington DC: American Society for Microbiology, January 2007, Journal of Virology, Vol. 81, pp. 3142-3150. DOI: 10.1128/JVI.02028-06; http://jvi.asm.org/content/81/7/3142. ISSN: 0022-538X.
  261. Curcumin Protects Mice From Coxsackievirus B3-Induced Myocarditis by Inhibiting the Phosphatidylinositol 3 kinase/Akt/Nuclear Factor-κB Pathway. Song, Yunxiao, et al., et al. [ed.] Robert A. Kloner. 6, Los Angeles: SAGE Publications, September 19, 2013, Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 18, pp. 560-569. DOI: 10.1177/1074248413503044; http://cpt.sagepub.com/content/18/6/560. ISSN: 1074-2484.
  262. Best ratio of curcumin with piperine for lowing lipid by method of uniform design. Zeng, Xiao-hui, et al., et al. Zeng, Xiao-hui, Zhao, Zi-ming and Chen, Yu-xing. 9, s.l.: Jilin Provincial Health Department, 2009, Jilin Medical Journal, Vol. 2009. CNKI:SUN:JLYX.0.2009-09-002. ISSN: 1004-0412.
  263. Renoprotective effect of the antioxidant curcumin: Recent findings. Trujillo, Joyce, et al., et al. [ed.] V.M. Darley-Usmar and T. Grune. 1, Birmingham; Jena: Elsevier B.V., 2013, Redox Biology, Vol. 1, pp. 448-456. DOI: 10.1016/j.redox.2013.09.003; http://www.sciencedirect.com/science/article/pii/S2213231713000670. ISSN: 2213-2317.
  264. Moreillon, Jennifer Josephine. Effects of eight weeks of curcumin and Boswellia serrata supplementation on plasma markers of inflammation and antioxidant activity in chronic kidney disease patients. Dept. of Health, Human Performance and Recreation, Baylor University. Waco: Baylor University's Digital Repository, 2010. Ph.D. Thesis.
  265. Curcumin Induces Nrf2 Nuclear Translocation and Prevents Glomerular Hypertension, Hyperfiltration, Oxidant Stress, and the Decrease in Antioxidant Enzymes in 5/6 Nephrectomized Rats. Tapia, Edilia, et al., et al. [ed.] Felipe Dal-Pizzol. Article ID 269039, Rio de Janeiro: Hindawi Publishing Corporation, June 4, 2012, Oxidative Medicine and Cellular Longevity, Vol. 2012, pp. 1-14. DOI: 10.1155/2012/269039; http://www.hindawi.com/journals/omcl/2012/269039/. ISSN: 1942-0900.
  266. Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5/6 nephrectomized rats: role of phospholipase and cyclooxygenase. Ghosh, S.S., et al., et al. [ed.] Thomas R. Kleyman. 4, Pittsburgh: The American Physiological Society, February 15, 2012, American Journal of Physiology - Renal Physiology, Vol. 302, pp. F439-F454. DOI: 10.1152/ajprenal.00356.2010; http://ajprenal.physiology.org/content/302/4/F439. ISSN: 1931-857X.
  267. Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen presenting cells. Rogers, N.M., et al., et al. [ed.] David R Poyner and Debbie L Hay. 1, Glasgow: John Wiley & Sons, Inc.: The British Pharmacological Society, May 2012, British Journal of Pharmacology, Vol. 166, pp. 194-209. DOI: 10.1111/j.1476-5381.2011.01590.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01590.x/abstract. eISSN: 1476-5381.
  268. Beneficial Effects of the Bioflavonoids Curcumin and Quercetin on Early Function in Cadaveric Renal Transplantation: A Randomized Placebo Controlled Trial. Shoskes, Daniel, et al., et al. 11, s.l.: Lippincott Williams & Wilkins, December 15, 2005, Transplantation, Vol. 80, pp. 1556-1559. DOI: 10.1097/01.tp.0000183290.64309.21; http://journals.lww.com/transplantjournal/pages/articleviewer.aspx?year=2005&issue=12150&article=00008&type=abstract. ISSN: 0041-1337.
  269. Curcumin Pretreatment Prevents Potassium Dichromate-Induced Hepatotoxicity, Oxidative Stress, Decreased Respiratory Complex I Activity, and Membrane Permeability Transition Pore Opening. García-Niño, Wylly Ramsés, et al., et al. [ed.] Shrikant Anant. Article ID 424692, Kansas City: Hindawi Publishing Corporation, July 17, 2013, Evidence-Based Complementary and Alternative Medicine, Vol. 2013, pp. 1-19. DOI: 10.1155/2013/424692; http://www.hindawi.com/journals/ecam/2013/424692/. eISSN: 1741-4288.
  270. Oral nanoparticulate curcumin combating arsenic-induced oxidative damage in kidney and brain of rats. Sankar, Palanisamy. [ed.] Alan M. Hoberman. Horsham: SAGE Publications, October 8, 2013, Toxicology and Industrial Health. DOI: 10.1177/0748233713498455; http://tih.sagepub.com/content/early/2013/10/04/0748233713498455. eISSN: 1477-0393.
  271. Protective effects of the dietary supplementation of turmeric (Curcuma longa L.) on sodium arsenite-induced biochemical perturbation in mice. Karim, Rezaul, et al., et al. [ed.] A.K. Khan. 3, Dhaka: Bangladesh Medical Research Council, December 2010, Bangladesh Medical Research Council Bulletin, Vol. 36, pp. 82-88. DOI: 10.3329/bmrcb.v36i3.7287; http://www.banglajol.info/index.php/BMRCB/article/view/7287. ISSN: 0377-9238.
  272. National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC). Polycystic Kidney Disease. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). [Online] September 2, 2010. [Cited: March 26, 2015.] http://kidney.niddk.nih.gov/kudiseases/pubs/polycystic/. NIH Publication No. 08-4008.
  273. Curcumin and analog 2a inhibit â-catenin pathway and ADPKD cyst growth. Bello-Reuss, Elsa, et al., et al. [ed.] Gerald Weissmann. Meeting Abstract Supplement 910.19, New York: Federation of American Societies for Experimental Biology, April 2013, The FASEB Journal, Vol. 27, p. 910.19. ISSN: 0892-6638.
  274. Pharmacological and clinical properties of curcumin. Beevers, Christopher S. and Huang, Shile. [ed.] Ayse Kuruuzum-Uz. Ankara: Dove Medical Press Ltd., June 23, 2011, Botanics: Targets and Therapy, Vol. 1, pp. 5-18. DOI: 10.2147/BTAT.S17244; http://www.dovepress.com/pharmacological-and-clinical-properties-of-curcumin-peer-reviewed-article-BTAT. ISSN: 1179-9897.
  275. A Pilot Study on Intravesical Administration of Curcumin for Cystitis Glandularis. Lu, Qiong, et al., et al. [ed.] Alfredo Vannacci. Article ID 269745, Prato: Hindawi Publishing Corporation, May 22, 2013, Evidence-Based Complementary and Alternative Medicine, Vol. 2013, pp. 1-5. DOI: 10.1155/2013/269745; http://www.hindawi.com/journals/ecam/2013/269745/. eISSN: 1741-4288.
  276. Antimicrobial Activity of Three Different Rhizomes of Curcuma Longa & Curcuma Aromatica on Uropathogens of Diabetic Patients. Saleem, Mehvish, Daniel, Betty and K, Murli. [ed.] Manish S. Bhatia. 4, Pune: Academic Sciences, Oct-Dec 2011, International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 3, pp. 273-279. ISSN: 0975-1491.
  277. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: A randomized, double-blind and placebo-controlled study. Khajehdehi, Parviz, et al., et al. [ed.] Per-Uno Malmström. 5, Stockholm: Informa Plc, November 2011, Scandinavian Journal of Urology, Vol. 45, pp. 365-370. DOI: 10.3109/00365599.2011.585622; http://informahealthcare.com/doi/abs/10.3109/00365599.2011.585622. ISSN: 2168-1805.
  278. Brent, Lawrence H., Karhadkar, Arati and Bloom, Eric. Lupus Nephritis. Medscape. [Online] April 22, 2014. [Cited: March 26, 2015.] http://emedicine.medscape.com/article/330369-overview#showall.
  279. Capsicum, Rosemary, and Turmeric. [book auth.] Manuchair Ebadi. Pharmacodynamic Basis of Herbal Medicine. 2. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2007, 19, pp. 237-238. ISBN: 0-8493-7050-7.
  280. A Current Update on the Rule of Alternative and Complementary Medicine in the Treatment of Liver Diseases. Guan, Yong-Song and He, Qing. [ed.] Mohammad Ahmad Al-Shatouri. Article ID 321234, Ismaileya: Hindawi Publishing Corporation, September 10, 2013, Evidence-Based Complementary and Alternative Medicine, Vol. 2013, pp. 1-10. DOI: 10.1155/2013/321234; http://www.hindawi.com/journals/ecam/2013/321234/. eISSN 1741-4288.
  281. Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1. Kang, Qiaohua and Chen, Anping. [ed.] Gene P. Siegal. 11, Birmingham: Nature Publishing Group: United States and Canadian Academy of Pathology, November 2009, Laboratory Investigation, Vol. 89, pp. 1275-1290. DOI: 10.1038/labinvest.2009.93; http://www.nature.com/labinvest/journal/v89/n11/full/labinvest200993a.html. ISSN: 0023-6837.
  282. Pharmacological actions of curcumin in liver diseases or damage. Rivera-Espinoza, Yadira and Muriel, Pablo. [ed.] Rajiv Jalan. 10, Calgary: John Wiley & Sons Ltd, November 2009, Liver International, Vol. 29, pp. 1457-1466. DOI: 10.1111/j.1478-3231.2009.02086.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1478-3231.2009.02086.x/abstract. eISSN: 1478-3231.
  283. Acetaminophen-Induced Nephrotoxicity: Pathophysiology, Clinical Manifestations, and Management. Mazer, Maryann and Perrone, Jeanmarie. [ed.] Leslie R. Dye. 1, Waynesville: Springer-Verlag, March 1, 2008, Journal of Medical Toxicology, Vol. 4, pp. 2-6. DOI: 10.1007/BF03160941; http://link.springer.com/article/10.1007%2FBF03160941. ISSN: 1556-9039.
  284. Activation of peroxisome proliferator-activated receptor-γ contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Xu, Jianye, Fu, Yumei and Chen, Anping. [ed.] Marshall Montrose. 1, Bethesda: The American Physiological Society, July 1, 2003, AJP - Gastrointestinal and Liver Physiology, Vol. 285, pp. G20-G30. DOI: 10.1152/ajpgi.00474.2002; http://ajpgi.physiology.org/content/285/1/G20. ISSN: 0193-1857.
  285. The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study. Kim, Sang-Wook, et al., et al. [ed.] Tom Rowles. 58, London: BioMed Central Ltd.: International Society for Complementary Medicine Research, March 8, 2013, BMC Complementary and Alternative Medicine, Vol. 13. DOI: 10.1186/1472-6882-13-58; http://www.biomedcentral.com/1472-6882/13/58. ISSN: 1472-6882.
  286. Prevention of hepatotoxicity due to anti tuberculosis treatment: A novel integrative approach. Adhvaryu, Meghna R., Reddy, Narsimha M. and Vakharia, Bhasker C. [ed.] Lian-Sheng Ma. 30, Hong Kong: Baishideng Publishing Group Co., Limited, August 14, 2008, World Journal of Gastroenterology, Vol. 14, pp. 4753-4762. DOI: 10.3748/wjg.14.4753; http://www.wjgnet.com/1007-9327/14/4753.asp. ISSN: 1007-9327.
  287. Comparative effects of curcumin and resveratrol on aflatoxin B1-induced liver injury in rats. El-Agamy, Dina S. [ed.] Jan G. Hengstler. 5, Dortmund: Springer-Verlag, May 2010, Archives of Toxicology, Vol. 84, pp. 389-396. DOI: 10.1007/s00204-010-0511-2; http://link.springer.com/article/10.1007%2Fs00204-010-0511-2. ISSN: 0340-5761.
  288. National Toxicology Program. Report on Carcinogens - 12th Edition. s.l.: U.S. Department of Health and Human Services, 2011.
  289. Biochemical Studies on the Role of Curcumin in the Protection of Liver and Kidney Damage by Anti-Malaria Drug, Chloroquine. Al-Jassabi, S., Azirun, Mohd Sofian and Saad, Ali. [ed.] Rachid Rouabhi. 1, Tebessa: IDOSI Publications, 2011, American-Eurasian Journal of Toxicological Sciences, Vol. 3, pp. 17-22. ISSN: 2079-2050.
  290. Advance in the pathogenesis and treatment of Wilson disease. Dong, Qin-Yun and Wu, Zhi-Ying. [ed.] Shengdi Chen. 23, Shanghai: BioMed Central Ltd., November 27, 2012, Translational Neurodegeneration, Vol. 1. DOI: 10.1186/2047-9158-1-23; http://www.translationalneurodegeneration.com/content/1/1/23. ISSN: 2047-9158.
  291. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. Kell, Douglas B. [ed.] Tim Sands. 2, London: BioMed Central Ltd., January 8, 2009, BMC Medical Genomics, Vol. 2. DOI: 10.1186/1755-8794-2-2; http://www.biomedcentral.com/1755-8794/2/2. ISSN: 1755-8794.
  292. Protective and modulatory effects of Curcumin and L-Carnitine against Methotrexate-induced Oxidative stress in albino rats. Abdel-Ghaffar, Faten R., et al., et al. [ed.] P. Gopkumar and K. Girish. 1, Surat: GVGS, January-March 2013, Research Journal of Pharmaceutical, Biological and Chemical Sciences, Vol. 4, pp. 744-754. ISSN: 0975-8585.
  293. Hepatic Failure Despite Early Acetylcysteine Following Large Acetaminophen-Diphenhydramine Overdose. Wang, George S., et al., et al. [ed.] Lewis R. First. 4, Burlington: American Academy of Pediatrics, April 1, 2011, Pediatrics, Vol. 127, pp. e1077-e1080. DOI: 10.1542/peds.2010-2521; http://pediatrics.aappublications.org/content/127/4/e1077. ISSN: 0031-4005.
  294. Curcumin protects rats against acetaminophen-induced hepatorenal damages and shows synergistic activity with N-acetyl cysteine. Kheradpezhouh, Ehsan, et al., et al. [ed.] F.P. Nijkamp. 1-3, Utrecht: Elsevier B.V., February 25, 2010, European Journal of Pharmacology, Vol. 628, pp. 274-281. DOI: 10.1016/j.ejphar.2009.11.027; http://www.sciencedirect.com/science/article/pii/S0014299909010425. ISSN: 0014-2999.
  295. Piperine and Quercetin Enhances Antioxidant and Hepatoprotective effect of Curcumin in Paracetamol Induced Oxidative Stress. Mehta, Astha, Kaur, Ginpreet and Chintamaneni, Meena. [ed.] Majid Y. Moridani. 2, Denver: Asian Network for Scientific Information, 2012, International Journal of Pharmacology, Vol. 8, pp. 101-107. ISSN: 1811-7775.
  296. Curcumin Exposure Modulates Multiple Pro-Apoptotic and Anti-Apoptotic Signaling Pathways to Antagonize Acetaminophen-Induced Toxicity. Bulku, Elida, et al., et al. [ed.] Kenneth Maiese. 1, Newark: Bentham Science Publishers, February 1, 2012, Current Neurovascular Research, Vol. 9, pp. 58-71. DOI: 10.2174/156720212799297083; http://www.eurekaselect.com/76453/article. ISSN: 1567-2026.
  297. Stritch School of Medicine. Schistosoma. Loyola University. [Online] [Cited: March 26, 2015.] http://www.meddean.luc.edu/lumen/meded/mech/cases/case14/schistos.htm.
  298. Effect of Curcuma longa or parziquantel on Schistoma mansoni infected mice liver - Histological and histochemical study. El-Banhawey, Mahmoud A, et al., et al. [ed.] K. Satyanarayana. 10, New Delhi: Indian Council of Medical Research, October 2007, Indian Journal of Medical Research, Vol. 45, pp. 877-889. ISSN: 0971-5916.
  299. Natural Products as a Source for Treating Neglected Parasitic Diseases. Ndjonka, Dieudonné, et al., et al. [ed.] Chang Won Choi. 2 (Plant-Derived Pharmaceuticals by Molecular Farming), Basel: MDPI AG, February 6, 2013, International Journal of Molecular Sciences, Vol. 14, pp. 3395-3439. DOI: 10.3390/ijms14023395; http://www.mdpi.com/1422-0067/14/2/3395. ISSN: 1422-0067.
  300. Study of curcumin on liver fibrosis of mice with schistosmiasis japonica. Chen, Hui and Liu, Wen. 19, Hubei: Chinese Pharmaceutical Association, 2008, Chinese Journal of Hospital Pharmacy, Vol. 2008, pp. 1679-1682. ISSN: 1001-5213.
  301. Canavan, Neil. More Nonalcoholic Steatohepatitis Requiring Transplant. Medscape Medical News - The Liver Meeting 2011: American Association for the Study of Liver Diseases (AASLD) 62nd Annual Meeting. [Online] November 28, 2011. [Cited: March 26, 2015.] http://www.medscape.com/viewarticle/754220.
  302. Sears, Dawn, et al., et al. Fatty Liver: Overview; Treatment & Management. Medscape Reference: Drugs, Diseases & Procedures. [Online] December 14, 2014. [Cited: March 26, 2015.] http://emedicine.medscape.com/article/175472-overview#showall.
  303. OC-053 Curcumin, Anti-Oxidant, and Pioglitazone Therapy with Inclusion of Vitamin E in Non Alcoholic Fatty Liver Disease-A Randomized open Label Placebo Controlled Clinical Prospective Trial (Captive). Basu, P, et al., et al. [ed.] Emad El-Omar. Supplement 1, Aberdeen: BMJ Publishing Group Ltd & British Society of Gastroenterology, June 2013, Gut, Vol. 62, p. A23. DOI: 10.1136/gutjnl-2013-304907.052; http://gut.bmj.com/content/62/Suppl_1/A23.2. eISSN: 1468-3288.
  304. Curcumin Inhibits srebp-2 Expression in Activated Hepatic Stellate Cells in Vitro by Reducing the Activity of Specificity Protein-1. Kang, Qiaohua and Chen, Anping. [ed.] Jeffrey D. Blaustein. 12, Boston: The Endocrine Society, December 1, 2009, Endocrinology, Vol. 150, pp. 5384-5394. DOI: 10.1210/en.2009-0517; http://press.endocrine.org/doi/abs/10.1210/en.2009-0517. ISSN: 0013-7227.
  305. Curcumin Eliminates Leptin's Effects on Hepatic Stellate Cell Activation via Interrupting Leptin Signaling. Tang, Youcai, Zheng, Shizhong and Chen, Anping. [ed.] Jeffrey D. Blaustein. 7, Boston: The Endocrine Society, July 1, 2009, Endocrinology, Vol. 150, pp. 3011-3020. DOI: 10.1210/en.2008-1601; http://press.endocrine.org/doi/abs/10.1210/en.2008-1601. ISSN: 0013-7227.
  306. High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats. Meli, Rosaria, et al., et al. [ed.] Silvana Gaetani. 6, Rome: Public Library of Science, June 21, 2013, PLoS ONE, Vol. 8, p. e66570. DOI: 10.1371/journal.pone.0066570; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066570. ISSN: 1932-6203.
  307. Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. Kim, KyeongJin, et al., et al. [ed.] Felix Wieland. 4, Heidelberg: Elsevier B.V., February 19, 2010, FEBS Letters, Vol. 584, pp. 707-712. DOI: 10.1016/j.febslet.2009.12.019; http://www.febsletters.org/article/S0014-5793(09)01065-5/abstract. ISSN: 0014-5793.
  308. Wan, Lei. Evidence-based Anticancer Materia Medica for Hepatocellular Carcinoma. [ed.] William C.S. Cho. Materia Medica for Various Cancers. London: Springer Science+Business Media B.V., 2012, Vol. 2, 5, pp. 89-102. ISBN: 978-94-007-1982-8.
  309. Urban legends series: lichen planus. Baccaglini, L., et al., et al. [ed.] Bruce Baum and Crispian Scully. 2, Oxford: John Wiley & Sons A/S, March 2013, Oral Diseases, Vol. 19, pp. 128-143. DOI: 10.1111/j.1601-0825.2012.01953.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1601-0825.2012.01953.x/abstract. ISSN: 1601-0825.
  310. Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1α. Rechtman, Maya Mouler, et al., et al. [ed.] Hans-Dieter Klenk. 11, Marburg: Elsevier B.V., June 3, 2010, FEBS Letters, Vol. 584, pp. 2485-2490. DOI: 10.1016/j.febslet.2010.04.067; http://www.febsletters.org/article/S0014-5793(10)00352-2/abstract. ISSN: 0014-5793.
  311. Delang, Leen, et al., et al. Hepatitis C Virus-Specific Directly Acting Antiviral Drugs. [ed.] Ralf Bartenschlager. Hepatitis C Virus: From Molecular Virology to Antiviral Therapy. Heidelberg: Springer-Verlag Berlin Heidelberg, 2013, Vol. 369, pp. 289-320. ISBN: 978-3-642-27339-1.
  312. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. Kim, Hye Jin, et al., et al. [ed.] R. Verpoorte. 2, Leiden: Elsevier Ireland Ltd., July 15, 2009, Journal of Ethnopharmacology, Vol. 124, pp. 189-196. DOI: 10.1016/j.jep.2009.04.046; http://www.sciencedirect.com/science/article/pii/S0378874109002700. ISSN: 0378-8741.
  313. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Anggakusuma, et al., et al. [ed.] Emad El-Omar. 7, Aberdeen: BMJ Publishing Group Ltd & British Society of Gastroenterology, July 13, 2014, Gut, Vol. 63, pp. 11374-1149. DOI: 10.1136/gutjnl-2012-304299; http://gut.bmj.com/content/63/7/1137. eISSN: 1468-3288.
  314. A Controlled Clinical Study between Hepatic Arterial Infusion with Embolized Curcuma Aromatic Oil and Chemical Drugs in Treating Primary Liver Cancer. Cheng, Jian-hua, et al., et al. [ed.] Chen Ke-ji. 2, Beijing: Chinese Association of Traditional and Western Medicine, China Academy of Chinese Medical Sciences, June 1, 2001, Chinese Journal of Integrated Traditional and Western Medicine, Vol. 7, p. 141. ISSN: 1006-6497.
  315. Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT. Chen, Ming-Ho, et al., et al. [ed.] Demetrios A. Spandidos. 5, Athens: Spandidos Publications, November 2012, International Journal of Molecular Medicine, Vol. 30, pp. 1021-1028. DOI: 10.3892/ijmm.2012.1096; http://www.spandidos-publications.com/10.3892/ijmm.2012.1096. ISSN: 1107-3756.
  316. Calabrese, Vittorio, et al., et al. Phenolics in Aging and Neurodegenerative Disorders. [ed.] Cesar G. Fraga. Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology. Hoboken: John Wiley & Sons, Inc., 2010, 18, pp. 427-452. ISBN: 978-0-470-28721-7.
  317. Inhibitory effects of crude extracts from some edible Thai plants against replication of hepatitis B virus and human liver cancer cells. Waiyaput, Wanwisa, et al., et al. [ed.] Tom Rowles. 246, London: BioMed Central Ltd., December 6, 2012, BMC Complementary and Alternative Medicine, Vol. 12. DOI: 10.1186/1472-6882-12-246; http://www.biomedcentral.com/1472-6882/12/246. ISSN: 1472-6882.
  318. Control of cccDNA function in hepatitis B virus infection. Levrero, Massimo, et al., et al. [ed.] Massimo Colombo. 3, Milan: Elsevier Inc.: European Association for the Study of the Liver, September 2009, Journal of Hepatology, Vol. 51, pp. 581-592. DOI: 10.1016/j.jhep.2009.05.022; http://www.journal-of-hepatology.eu/article/S0168-8278(09)00389-4/abstract. ISSN: 0168-8278.
  319. Chemopreventive Effect of Curcuma longa Linn on Liver Pathology in HBx Transgenic Mice. Kim, Jungsun, et al., et al. [ed.] Keith I. Block. 2, Chicago: Sage Publications, December 29, 2010, Integrative Cancer Therapies, Vol. 10, pp. 168-177. DOI: 10.1177/1534735410380613; http://ict.sagepub.com/content/10/2/168. ISSN: 1534-7354.
  320. Khan, Ikhlas A. and Abourashed, Ehab A. Leung's Encyclopedia of Common Natural Ingredients: Used in Food, Drugs and Cosmetics. 3. Hoboken: John Wiley & Sons, Inc., 2010. ISBN: 978-0-471-46743-4.
  321. Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial. Panahi, Yunes, et al., et al. [ed.] Robbert van Haselen. 5, Kingston, Surrey: Elsevier Inc., October 2014, Complementary Therapies in Medicine, Vol. 22, pp. 851-857. DOI: 10.1016/j.ctim.2014.07.006; http://www.complementarytherapiesinmedicine.com/article/S0965-2299(14)00114-9/abstract. ISSN: 0965-2299.
  322. Curcumin improves intestinal barrier function: Modulation of intracellular signaling and organization of tight junctions. Wang, Jing, Ghosh, Siddhartha S. and Ghosh, Shobha. [ed.] Josephine Adams. 4, Bristol: American Physiological Society, March 1, 2017, American Journal of Physiology - Cell Physiology®, Vol. 314, pp. C438-C445. DOI: 10.1152/ajpcell.00235.2016; http://ajpcell.physiology.org/content/early/2017/02/23/ajpcell.00235.2016. ISSN: 0363-6143; PMID: 28249988.
  323. Turmeric-based beverage blunted acute high fat meal-induced oxidative stress by lowering serum malondialdehyde (MDA) levels: a randomized cross-over study. Zanzer, Yoghatama Cindya, et al., et al. [ed.] Veronika Butterweck. S01, Muttenz: Georg Thieme Verlag KG, December 14, 2016, Planta Medica, Vol. 82, pp. S1-S381. DOI: 10.1055/s-0036-1596975; https://www.thieme-connect.de/DOI/DOI?10.1055/s-0036-1596975. ISSN: 0032-0943.
  324. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial. Panahi, Yunes, et al., et al. [ed.] Kathi J. Kemper. Columbus: Elsevier Inc., August 2017, Complementary Therapies in Medicine, Vol. 33, pp. 1-5. DOI: 10.1016/j.ctim.2017.05.006; http://linkinghub.elsevier.com/retrieve/pii/S0965229917303370. ISSN: 0965-2299.
  325. Non-HDL-C is a Better Predictor for the Severity of Coronary Atherosclerosis Compared with LDL-C. Zhang, Yan, et al., et al. [ed.] A. Robert Denniss. 10, Sydney: Elsevier B.V.: Australian and New Zealand Society of Cardiac and Thoracic Surgeons; Cardiac Society of Australia and New Zealand, October 2016, Heart, Lung and Circulation, Vol. 25, pp. 975-981. DOI: 10.1016/j.hlc.2016.04.025; http://linkinghub.elsevier.com/retrieve/pii/S1443950616302608. ISSN: 1443-9506; PMID: 27634241.
  326. Lipoprotein (a) level, apolipoprotein (a) size, and risk of unexplained ischemic stroke in young and middle-aged adults. Beheshtian, Azadeh, et al., et al. [ed.] A. von Eckardstein. Zürich: Elsevier Ireland Ltd., October 2016, Atherosclerosis, Vol. 253, pp. 47-53. DOI: 10.1016/j.atherosclerosis.2016.08.013; http://www.atherosclerosis-journal.com/article/S0021-9150(16)31262-X/fulltext. ISSN: 0021-9150; PMID: 27575936.
  327. Curcumin for maintenance of remission in ulcerative colitis. Garg, Sushil K., et al., et al. [ed.] Cochrane IBD Group. s.l.: John Wiley & Sons, Ltd., October 17, 2012, Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.CD008424.pub2; http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008424.pub2/abstract. ISSN: 1469-493X; PMID: 23076948.
  328. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial. Salomon, Nir, et al., et al. [ed.] Hashem B. El-Serag. 8, Houston: Elselvier: Saunders, August 2015, Clinical Gastroenterology and Hepatology, Vol. 13, pp. 1444-1449.e1. DOI: 10.1016/j.cgh.2015.02.019; http://www.cghjournal.org/article/S1542-3565(15)00158-5/fulltext. ISSN: 1542-3565; PMID: 25724700.
  329. Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial. Kedia, Saurabh, et al., et al. [ed.] Hugh J. Freeman. 2, Vancouver: Baishideng Publishing Group Co., Limited, May 6, 2017, World Journal of Gastrointestinal Pharmacology and Therapeutics, Vol. 8, pp. 147-154. DOI: 10.4292/wjgpt.v8.i2.147; https://www.wjgnet.com/2150-5349/full/v8/i2/147.htm. eISSN: 2150-5349; PMID: 28533925.

Join the 1000s of People Who Are Discovering the Benefits of Turmeric.


Buy Now
New Vegan, Cruelty Free, Non GMO, Stearate Free, Gluten Free Turmeric Health Supplement Made in the USA in a GMP-certified, FDA-approved facility.

Healthceuticals® Turmeric Curcumin Complex

100% Certified
Organic ingredients

  • Organic Turmeric Extract - standardized to 95% curcuminoids.
  • Organic Whole Turmeric - provides full spectrum antioxidant, anti-inflammatory turmeric benefits, including turmerones and numerous vitamins, minerals, and phytonutrients
  • Organic Black Pepper Extract - standardized to 95% piperine; dramatically enhances bioavailablity.
  • Organic Phospholipids - markedly improve absorption.
  • Organic Ginger - works synergistically with turmeric to provide more powerful benefits.
  • Absolutely FREE of potentially harmful additives and fillers such as magnesium stearate.
Vegan | Cruelty Free | Non GMO | Stearate Free | Gluten Free Made in the USA in a GMP-certified, FDA-approved facility
Disclaimer: This website is not intended to replace professional consultation, diagnosis, or treatment by a licensed physician. If you require any medical related advice, contact your physician promptly. Information at this website is exclusively of a general reference nature. Do not disregard medical advice or delay treatment as a result of accessing information at this site.